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         Abstract
Sorangicin is a macrolide polyether antibiotic which was isolated from  Sorangium Cellu-
losum.  The structural  complexity and exciting biological  activity of sorangicin have pro-
moted our effort to develop an efficient and effective synthetic approach to fragments of sor-
angicin. To date there have been one total synthesis of sorangicin A and three partial syn-
theses reported. In this work a new modern and compact method for synthesizing the C(1)-
C(19) fragment of sorangicin A has been evaluated and as well as a new approach for syn-
thesizing the L-glucose fragment was developed. The construction of fragment III started by 
synthesizing fragment D, fragment E and fragment F. Fragment D was synthesized in twelve 
steps by starting from ethylene glycol and cis-2-butenediol. The ethylene glycol 170 was se-
lectively protected and oxidized to give TBS-protected aldehyde 18 and subsequent enanti-
oselective aldol reaction using D-proline as catalyst furnished the aldol product 23. The cis-
2-butenediol 173 was converted into the corresponding alkene 22 in three steps. The aldol 23 
and TMS-protected alkene  22 underwent Mukaiyama aldol reaction using MgBr2.Et2O and 
subsequent treatment with HBr/AcOH afforded TBS-protected glucal  25  which underwent 
carbon-Ferrier rearrangement and oxidized using Sharpless condition to give 31. The alde-
hyde  31 was protected,  deprotected,  underwent Grignard addition and oxidized to afford 
ketone 180. Deprotection of methyl ketone 180, Mitsunobu inversion and finally protection 
with TBSCl afforded fragment  D. Fragment  E was synthesized by starting from D-valine 
which afforded in  three  steps  Seebach auxiliary  3.  The auxiliary  3  and 6-heptenoic-acid 
chloride 4 were coupled using n-BuLi and the coupled product 5 was changed in three steps 
to the corresponding alcohol 7. Subsequent Mitsunobu reaction condition and oxidation fur-
nished the corresponding sulfones, fragment  E and benzothiazole sulfone  14. Fragment  F 
was synthesized in three steps from 1,4-butanediol. The synthesis of fragment III was tested 
by coupling fragment D, fragment E and fragment F using modified Julia olefination by em-
ploying LiHMDS, KHMDS, NaHMDS, LDA and t-BuLi as bases. Different coupling reac-
tion conditions were evaluated including both premetallate and barbier conditions to couple 
the fragments.  
Zusammenfassung                                                                                                                    v
    
Zusammenfassung
Sorangicin ist ein Makrolid-Polyether-Antibiotikum das aus  Sorangium cellulosum isoliert 
wurde. Die strukturelle Komplexität und interessante biologische Aktivität von Sorangicin 
haben uns in unseren  Bemühungen, einen  effizienten und effektiven synthetischen Ansatz 
für die Fragmente von Sorangicin zu entwickeln, gestärkt. Bisher ist eine Totalsynthese von 
Sorangicin  A bekannt und es ist von drei Teilsynthesen  berichtet worden.  In dieser Arbeit 
wurde  ein  neues,  modernes  und  kompaktes  Verfahren  zur  Synthese  des  C(1)-C(19)-
Fragment  von  Sorangicin  A getestet,  sowie  ein  neuer  Ansatz  für  die  Synthese  des  L-
Glucose-Fragmentes entwickelt. Die Synthese von Fragment  III baut auf die Synthese von 
Fragment  D, Fragment  E und  Fragment F auf. Fragment  D wurde,  ausgehend  von 
Ethylenglykol und cis-2-Butendiol in zwölf Stufen in einer Gesamtausbeute von über 25% 
synthetisiert. Ethylenglykol  170 wurde selektiv geschützt und oxidiert um den geschützten 
Aldehyd 18 zu erhalten. Die anschließende enantioselektive Aldolreaktion mit D-Prolin als 
Katalysator lieferte das Aldolprodukt 23. Aus cis-2-Butendiol 173 wurde in drei Stufen das 
entsprechend geschützte Alken 22 gebildet. Das Aldolprodukt 23 und das geschützte Alken 
22 wurden  einer  Mukaiyama-Aldolreaktion  mit  MgBr2.Et2O  unterzogen  und  weiter  mit 
HBr/AcOH behandelt, um das TBS-geschützte Glucal  25 zu erhalten.  Um Fragment  D zu 
erhalten,  wurde  das  Glucal  25  einer  Carbon-Ferrier-Umlagerung  und  einer  Sharpless-
Oxidation  unterzogen,  danach  geschützt  und  wieder  entschützt,  einer  Grignard-Addition 
unterzogen  und  schließlich  oxidiert. Das  so  erhaltene  Methylketon  180  wurde  mittels 
Entschützung,  Mitsunobu-Inversion  und  abschließendes  TBS-Schützung  in  Fragment  D 
überführt.  Fragment  E wurde ausgehend von D-Valin synthetisiert, welches zunächst nach 
drei Stufen das Seebach-Auxiliar 3 lieferte. Das Auxiliar 3 wurde mit 6-Heptensäurechlorid 
4 zum  Produkt  5 gekuppelt.  Das  Kupplungsprodukt  5 wurde  über  drei  Stufen  zum 
entsprechenden Alkohol  7  umgewandelt und über eine anschließende Mitsunobu-Reaktion 
und Oxidation konnten die entsprechenden Sulfone,  Fragment  E und  14  erhalten werden. 
Die Synthese von Fragment  III wurde durch die Kopplung von Fragment  D, Fragment  E 
und Fragment   F mittels modifizierter Julia-Olefinierung durch den Einsatz von KHMDS, 
NaHMDS,  LDA  und  t-BuLi  als  Base  getestet.  Weiterhin  wurde  u.a.  der  Einfluß  der 
Reaktionsführung (Prämetallieg.  bzw.  Barbierbedingungen) untersucht. 
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Chapter 1- Background
Natural  products  have  been major  sources  of  medicine  in  the  last  few decades  and the 
development of various screening approaches improved the ease with which natural products 
can be used in drug discovery. Natural products can be extracted from various resources 
including plants, marine world, microorganisms, animals, venoms and toxins. Plants have 
always been a rich source of lead compounds (morphine, cocaine, nicotine). Many of these 
lead compounds are useful drugs in themselves (morphine) and others have been basis for 
synthetic drugs (local anesthetics developed from cocaine). Clinically useful drugs which 
have been recently isolated from plants include anticancer agent paclitaxel (taxol) from yew 
tree. Microorganisms such as bacteria and fungi have been invaluable for discovering drugs 
and lead compounds (Sorangicin, Epothilone). Soil and water samples collected have been 
leading to an impressive arsenal of antibacterial and antagonist agents such as cephalosporin, 
tetracycline,  and amino glycosides.  The marine  world has been a  source of biologically 
potent chemicals with interesting inflammatory, antiviral, and anticancer activity. Antitumor 
agents  derived  from  marine  sources  includes,  curacin,  discodermolide,  and  lovastatin. 
Animals  can  sometimes  be  a  source  of  new lead  compounds.  For  example,  a  series  of 
peptide antibiotics were extracted from skin of the African clawed frog. Epibatidine, potent 
analgesic, was obtained from the skin extracts of Ecuadorian frog. Venoms and toxins have 
been used as lead sources in the development of novel drugs such as teprotide, a peptide 
isolated from venom of the Brazilian viper, was the lead compound for the development of 
antihypertensive agents cilazapril and captopril. 
The reasons for the success of natural products are their great structural diversity and the fact 
that  evolution  over  millions  of  years  preselected  these  compounds  for  interaction  and 
activity. The dominance and pharmaceutical success of natural products is most obvious in 
the field of antibiotics. This was particularly evident in the areas of cancer and infectious 
diseases, where over 60% and 75% of these drugs, respectively, were shown to be of natural 
product origin[1]. Most antibacterial drugs introduced worldwide in the last three decades can 
be traced to natural products.  It is surprising that more than 200 antibacterial drugs which 
have been launched for human therapy since the invention of sulfonamides by Domagk in 
1935[2] belong to a limited number of antibacterial  classes. From 11 antibacterial  classes 
introduced for systemic use in humans, 8 are derived from natural products[4].
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Despite  the  overall  success  of  natural  products  and the  fact  that  antibiotics  have  saved 
millions  of lives, downsizing or even termination of both natural  products and antibiotic 
research have been observed in large pharmaceutical companies[4] in the last decade. Reasons 
for the decline of natural products research includes the following: (i) traditional extract-
based screening leads to the rediscovery of previously known compounds;  (ii)  structural 
complexity of natural products made total synthesis and derivation of them more difficult; 
(iii) because of supply problems, the time required to develop a natural product from an 
extract  hit  to  a  pharmaceutical  drug  is  long;  (iv)  focus  on  combinatorial  chemistry  to 
generate  huge  compound  library  is  needed  to  fulfill  the  demand  of  high-throughput- 
screening (HTS) technologies.
There are several reasons underlying the urgent need for new antibiotics, firstly, the fact that 
infectious  diseases  are  still  the  second major  cause  of  death  worldwide[4].  Secondly  the 
emergence and spread of multi-resistant pathogens particularly in the hospital environment 
as  well  as  constant  decrease  in  the  total  number  of  antibacterial  agents  that  have  been 
approved by drug controlling authorities.
1.1 Introduction
Gliding bacteria are a fascinating group of diverse microorganisms which have adapted to 
environments such as hydrothermal vents, tropical rainforests, marine shores, wastewater, 
deserts and intestinal tract of man and animals[3]. Due to their ubiquitous occurrence, gliding 
bacteria  play  a  major  role  in  microbial  ecology.  Gliding  is  defined  as  a  slow  surface 
associated translocation of a non-flagellated cell in the direction of its long axis. Bacteria 
with  gliding  motility  are  known  from  both  Gram-positive  and  Gram-negative  genera, 
crossing the entire spectrum of physiological types. Creeping movement is a consistent trait 
within  the  chloroflexi  which  represents  the  only  phylum  consisting  exclusively  gliding 
bacteria.  However most  gliding  species  originate  from cyanobacteria,  proteobacteria  and 
bacteroidetes. Based on their physiology gliding bacteria can be roughly divided into two 
distinct  groups.  The first  group consists  of  heterotrophic  organisms,  heterotrophs,  which 
decomposes macromolecular  substrates such as proteins and polysaccharides.  This group 
lack  genes  required  for  an  endogenous  production  of  certain  amino  acids  as  a  result 
predation has evolved as a reliable alternative to biosynthesis for this group. It comprises 
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myxobacteria, lysobacter, herpetosiphon, cytophaga and flavobacterium. The second group, 
phototrophs  and  autotrophs,  produce  complex  carbohydrates,  fats,  and  proteins  by 
themselves,  exhibit  an  autotrophic  way  of  life.  The  group  covers  cyanobacteria, 
proteobacteria,  thiothrix,  achromatium,  beggiatoa and  thioploca.  The autotrophs typically 
use  gliding  motility  in  order  to  adapt  to  shifting  growth conditions  within  their  natural 
habitat.
In the last four decades there have been an increase in the interest of research on gliding 
bacteria due to their great potential as source of potent natural products. Some of the potent 
natural  products  include  angiolam,  antibacterial  macrolide  agent,  which  inhibits  protein 
synthesis.  Phenalamide,  antifungal  and  anti-HIV  polyene  agent.  Epothilone,  a  cytotoxic 
macrolide which inhibits tubulin depolymerization. Myxochromide, a lipopeptide which acts 
as a pigment. Ripostatin, an antibacterial macrolide agent which inhibits RNA polymerase. 
Sorangicin, an antibacterial macrolide agent that inhibits RNA polymerase.
1.2 Myxobacteria as Proficient Producers of Novel Natural Products
The myxobacteria are a group of Gram-negative eubacteria belonging to the delta group of 
proteobacteria. They were originally isolated in 1892 by Roland Thaxter[5] who recognized 
them as a distinct and unusual group of bacteria. They are common in animal dung and or-
ganic-rich soils of neutral or alkaline medium. They are found everywhere, in all climate 
zones and vegetation belts, but are particularly numerous in semi-arid, warm areas such as 
Egypt, Northern India, and Southwestern United States. Some of them grow by utilizing cel-
lulose, but many of them feed themselves by secreting antibiotics to kill other bacteria and 
then produce an enzyme that lyses the cells of their prey. Myxobacteria have the largest gen-
omes known from bacteria and genome of one strain of sorangium cellulosum,  a cellulose 
degrader, which has been fully sequenced, is 13.04 Mbp long, about three times the size of 
the E. coli genome[3]. They are social bacteria with developed communication systems and 
produce fruiting bodies in starvation conditions. Fruiting bodies usually are 0.1-1mm in size 
and often can be recognized with the naked eye. Inside the maturing fruiting body, the veget-
ative cells convert into desiccation resistant myxospores and in this form the bacteria may 
survive 5-15 years of drought.  The vegetative cells of all myxobacteria are aerobic, elong-
ated rods with either rounded or tapered ends. They glide in water film across solid surfaces 
secreting slime (polysaccharide) tracks in which many cell migrate to produce feathery
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extensions at the colony margin. At the onset of nutrient depletion the cells migrate back 
along the slime tracks, aggregating by chemotaxis, to form large concentrations of cells.
Many compounds from myxobacteria are entirely new, mostly they are polyketides or pep-
tides often with very unusual amino acids and are synthesized by multienzyme complexes [3]. 
Myxobacteria has been source of many biologically active compounds such as rhizopodin 
which has a dramatic effect on cell morphology, chondramides which stimulate actin poly-
merization and stabilize the F-actin. Disorazol and tubulysin can be used as potential antic-
ancer drugs. Epothilone  which promotes tubulin polymerization and stabilizes microtubuli. 
Sorangicin a macrolide polyether antibiotic. The picture below represents a typical colony of 
myxobacteria (Figure. 1).
Figure. 1 Vegetative Cell of Myxobacteria Representative of the Suborder Cystobacterineae
1.3 Isolation and Structural Determination of Sorangicin
Sorangicin a macrolide polyether antibiotic which was first isolated in 1985 is a new class of 
macrolide natural products. The research groups of G. Höfle and H. Reichenbach [6] at the 
Helmholtz  Zentrum  fur  Infektionsforschung  in  Braunschweig,  Germany,  reported  the 
isolation of the novel antibiotic sorangicin from the gliding bacteria sorangium cellulosum. 
Importantly,  (+)-sorangicin  A,  the most  potent congener,  has demonstrated extraordinary 
antibiotic activity against a broad panel of both Gram-positive and Gram-negative bacteria. 
Subsequent mechanistic examination revealed that the selective biological response induced
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by sorangicin in prokaryotic cells arises from the inhibition of ribonucleic acid polymerase 
(RNAP). The minimal inhibitory concentration (MIC) values against Gram-negative bacteria 
range from 2-32 μg/ml  and for  Gram-positive  bacteria  the  MIC may be  less  10 μg/ml. 
Sorangicin has proved to be effective against experimental staphylococcal infections in rats 
and the mechanism of action has been shown to be the inhibition of the DNA dependent 
RNA  polymerase  in  staphylococcus  aureus and  E.  coli.  The  structure  of  sorangicin 
comprises a signature dioxabicyclo[3.2.1]octane skeleton in conjunction with a rare (Z,Z,E)-
trienoate  linkage,  both inscribed within  a highly unsaturated  31-membered macrolactone 
ring containing 15 stereogenic centers. The structure was determined by extensive use of 1H- 
NMR, 13C NMR, MS and UV data. From the main classes of sorangicin, sorangicin A and 
sorangicin  B,  (Figure. 2) have been studied in more details  compared with sorangioside 
(Figure. 2) and sorangicin C (Figure. 3). Sorangicin A has been effective antibiotic against 
tuberculosis and sorangicin B has been effective in treating hepatitis-B-virus.
Figure. 2 Classes of Sorangicin, Sorangicin A, Sorangicin B, Sorangioside
Figure. 3 Sorangicin C
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1.4 Overview of the Biological Activity of Sorangicin A    
A detailed study[7] into the structural, functional and genetic analysis of sorangicin suggests 
that sorangicin A is very much similar in antibiotic activity, with rifampicin (Figure. 4), an 
antibiotic which is commonly used to treat tuberculosis. This study revealed that sorangicin 
A lacks the chemical and structural similarity with  rifampicin, nevertheless it binds in the 
same antibiotic-binding subunit pocket as rifampicin.    
Figure. 4 Rifampicin
The results from sorangicin  A study[7] confirms that rifampicin and sorangicin  A binding 
sites of  RNA polymerase (RNAP) largely overlap. However the lack of cross-resistance at 
all of the tested positions suggests that there are subtle differences in the way the two antibi-
otics interact with RNAP. Functional analysis further revealed that the two antibiotics inhibit 
RNAP transcription in the same way, by blocking the synthesis of transcripts no longer than 
2–3 nucleotides in length. This is clearly by virtue of occupying the same site, which directly 
blocks the path of the elongating RNA product within the growing RNA/DNA hybrid. Sor-
angicin  A was observed to inhibit transcription initiation, but not elongation, similar to  ri-
fampicin. This genetic analysis also indicates that rifampicin is extremely sensitive to muta-
tions expected to change the shape of the antibiotic binding pocket but sorangicin A is not. 
This intrinsic conformational flexibility of sorangicin A allows it to adapt to change in the 
shape of the antibiotic binding pocket and this feature of sorangicin A has an important im-
plication in the design of drugs against rapidly mutating targets. The study also suggested 
that the three hydroxyls (C-21, C-22 and C-25) of sorangicin A are very important (Figure. 
5) for the antibiotic activity of sorangicin A. The two hydroxyls (C-21 and C-22) are critical 
for transcription inhibition as well as participate in hydrogen bonds when sorangicin inter-
acts with RNAP. Breaking the ring structure of  sorangicin, along with other chemical or 
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O OH
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stereochemical changes eliminates the antibiotic activity of sorangicin, suggesting that the 
overall structure of sorangicin is critical for its activity[8]. Sorangicin A, the myxobacterium 
Sorangium  (Polyangium)  cellulosum,  strain  So  ce12,  was  initially  isolated  from  a  soil 
sample in 1978 from Xcaret[9], Mexico. It has a molecular weight of 806 g/mol, and molecu-
lar formula, C47H66O11, which was confirmed by negative ion F.A.B mass spectrometry and 
elemental analysis[10].
Figure. 5 Biological Activity of Sorangicin A
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1.5 Prior Progress to the Total Synthesis of Sorangicin A 
1.5.1 Synthetic Efforts by Smith 
1.5.1.1 Synthesis of the THP Fragment
The Smith work group published the synthesis of the four fragments[11], [12] as well as the first 
total synthesis of sorangicin  A[13]. The Smith group developed synthetic route for the syn-
thesis of the bicyclic ether fragment, tetrahydropyran fragment (THP), dihydropyran frag-
ment (DHP), as well as the dienoate moiety. 
Scheme 1. Smith's Retrosynthesis of Sorangicin A
The synthesis of the THP fragment started by silylaton of the known conjugated β-hydroxy 
acid (+)-1 followed by condensation with the aldehyde (+)-2, facilitated by TMSOTf to af-
ford the dioxanone (+)-3 (Scheme 2). Petasis-Tebbe methylenation and exposure of the de-
rived enol ether to Me2AlCl to trigger Petasis-Ferrier rearrangement which provided tetrahy-
dropyranone (+)-4 in good yield. Reduction of (+)-4 with DIBAL-H resulted in best mixture 
(1:1) of C-25 axial and equatorial alcohols 5a, 5b.       
O
SO2PT
MOMO
O
OTBSO
A
O
O
t-BuO2C
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Bu3Sn
CO2Me
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O I
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Scheme 2. Initial THP Synthesis Trial
Because of the disappointing reduction result they turned their attention to aldol construction 
tactic with methyl ketone (+)-8 and aldehyde (+)-10. The construction of ketone (+)-8 was 
achieved via DIBAL-H reduction of lactone (+)-6 and treatment with trimethylsilyldiazo-
methane provided alcohol (+)-7. Compound (+)-7 underwent oxidation, methyl addition and 
oxidation consecutively to afford the methyl ketone (+)-8.  
Scheme 3. THP Synthesis
The treatment of boron enolate derived from (+)-8 with aldehyde (+)-10 furnished a separ-
able mixture (3.4:1) of C-25 diastereomers (Scheme 4). Removal of the TES group in 11a, 
11b followed by cyclization and methyl ketal formation furnished mixed methyl ketals
O
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(+)-12, (+)-13 in excellent yield. The minor diastereomer (+)-12 was completely converted 
to (+)-13 via oxidation and reduction. Reduction of methyl ketal  (+)-13 with  Et3SiH  pro-
moted by TMSOTf and MOM protection of the hydroxyl afforded tetrahydropyran fragment 
(+)-14 as a single diastereomer. Hydrozirconation/iodination followed by Suzuki-Miyaura 
coupling with alkyl boronate 15 next provided the trans olefin (+)-16. Removal of the benzyl 
group, protection of the diol and selective removal of the tert-butyldiphenylsilyl (BPS) group 
with hydroxide consecutively led to alcohol  (+)-17. Thio-ether formation of (+)-17 via a 
Mitsunobu reaction and oxidation of the sulfide to sulfone completed construction of frag-
ment  A. Sulfone (-)-A was thus prepared in 17 steps from commercially available starting 
material, with 17% overall yield. 
Scheme 4. Completion of THP Synthesis         
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1.5.1.2 Synthesis of the DHP Fragment
The synthesis of the DHP fragment B was started with enone (-)-24 exploiting a conjugate 
addition/oxygenation sequence.  Synthesis  of the requisite vinyl  bromide (-)-21 entailed a 
Myers alkylation between ketone (+)-18 and iodide 19 to furnish amide (+)-20. Reduction of 
amide (+)-20 followed by Corey-Fuchs homologation and hydrozirconation/bromination led 
to vinyl bromide (-)-21 as a single stereoisomer. Enone (-)-24 was prepared enantioselect-
ively via  cyclocondensation  between Danishefsky's  diene and aldehyde  22,  catalyzed  by 
chromium complex 23 (Scheme 5).
 Scheme 5. Synthesis of DHP Fragment
Treatment of the higher order cuprate derived from (-)-21 with enone (-)-24 (Scheme 6) in 
the presence of TESCl led to enol ether (+)-25 as a single diastereomer. Chemo- and ste-
reoselective C-10 oxidation of (+)-25 employing the Rubottom protocol followed by conver-
sion of the derived O-TES ether to O-TBS ether provided (-)-26. Kinetic enolate formation 
with LDA/HMPA followed in turn by formation of the enol triflate with Comin's reagent [N-
(5-chloro-2-pyridyl)-triflimide] and palladium catalyzed reduction led to diene (-)-27. Re-
moval of the PMB group followed by a two-step oxidation and tert-butyl ester formation fur-
nished (-)-28. Finally selective deprotection of the primary TBS group and Dess-Martin ox-
idation provided the DHP fragment. Overall, the synthesis of (-)-B entailed a longest linear 
sequence of 19 steps with 5% overall yield.
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Scheme 6. Completion of DHP Synthesis
1.5.1.3 Synthesis of the Bicyclic and Trienoate Fragments
Smith  et  al.  reported[11] the  synthesis  of  the  (Z,Z,E)-trienoate  linkage  and  dioxabicyclo- 
[3.2.1]octane. Synthesis of dihydropyranone (+)-34 was affected via an asymmetric Diels-
Alder reaction of aldehyde (-)-29 with Danishefsky's diene catalyzed by Cat. 30 followed by 
hydrolysis provided enol ether (-)-31 (Scheme 7). The treatment of enol ether (-)-31 with 
bromostyrene  32 by applying Noyori three-component coupling protocol involving lithium 
halogen exchange of bromine  with t-BuLi at -78 °C and followed by addition of Me2Zn 
warming to 0 °C furnished a mixed zincate 33. The enolate 33 was treated with HMPA and 
addition of CuI.PBu3 just prior to the addition of methyl iodide provided (+)-34. Stereose-
lective reduction of ketone (+)-34 resulted in alcohol (-)-35 and acidic deprotection provided 
triol (-)-36. Treatment of triol (-)-36 with isopropylbenzenesulfonyl chloride (TrisylCl)
i.  t-BuLi, THF
ii. CuCN
iii.TESCl
61%, 20:1 d.r.
O
OTES
H H
1) m-CPBA, CH2Cl2
2) PPTS, MeOH
3) TBSOTf, CH2Cl2
     3 steps, 46%
O
O
H H
OTBS
1) LDA, HMPA
    Comin's Reagent
2) Pd2(dba)3
.CHCl3
    PPh3, LiCl, BuSn3H
    2 steps, 71%
O
H H
OTBS 1) DDQ, CH2Cl2
2) DMP
3) NaClO2, NaHPO4
    2-methyl-2-butene
N
Ot-Bu
N
H
4 steps, 69%
O
t-BuO2C
H H
OTBS
1) HF.Py, Py
2) DMP
    2 steps, 65%
O
t-BuO2C
H H
OTBS
(+)-25
(-)-26 (-)-27
(-)-28 (-)-B
Br
(-)-21
PMBO
PMBO
PMBO PMBO
O
O
H
O
(-)-24
OTBS
OTBS
OTBS OTBS
OTBS
Theoretical Part                                                                                                                    13
afforded the primary sulfonate (-)-37. Exposure of (-)-37 to KHMDS effected both epoxide 
formation  and  subsequent  epoxide  opening  providing  the  five  membered  ring  bicyclic 
ether(-)-38. 
Scheme 7. Bicycles Synthesis 
The alcohol (-)-38 underwent Parikh-Doering oxidation followed by subjection of the crude 
aldehyde 39 to Takai olefination condition yielding vinyl iodide (-)-40 (Z) and (-)-41 (E) as 
diastereomeric mixture (Scheme 8). Finally selective dihydroxylation of the styrene-olefin 
(-)-41 followed by oxidative cleavage provided aldehyde (-)-C. The vinyl iodide (-)-41 was 
coupled with known vinyl (Z,Z)-dienoate 42 catalyzed by palladium and subsequent hydro-
lysis provided the bicyclic-triene carboxylic acid (+)-44.
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Scheme 8. Synthesis of Bicycles and Trienoate Fragments
1.5.1.4 First Total Synthesis of Sorangicin A
In a very recent paper Smith  et al. published[13] the first total synthesis of sorangicin  A in-
volving the coupling of the four fragments, dihydropyran (DHP), tetrahydropyran (THP), the 
bicycles and Stannyl dienoate fragments. Although the synthesis of the DHP fragment was 
already reported[12] from the group, the stereochemistry at C-10 of sorangicin A required ad-
justment (Scheme 9).  Global desilylation of (-)-28 followed by chemoselective silylation 
furnished allylic alcohol (-)-45. Ley oxidation and Luche reduction generated the desired al-
cohol (-)-46. Protection with TBSOTf and selective deprotection of the primary TBS group 
with HF.Py/Py-THF resulted in the primary alcohol (-)-47 and the alcohol was converted in 
two steps to sulfone (-)-48. 
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Scheme 9. Modification of DHP Synthesis
Smith  et al. started construction of both C(29)-C(30) and C(15)-C(16) trans double bonds 
via Julia-Kocienski olefination followed by Stille coupling and macrolactonization to com-
plete the overall carbon skeleton. Coupling between (-)-C and (-)-A using t-BuLi in aprotic 
solvent (DMF/HMPA) provided iodide (-)-49 with E-configuration (Scheme 10). The vinyl 
iodide  (-)-49 was converted  in  two steps  to  the corresponding aldehyde  (-)-50 and sub-
sequent  Julia-Kocienski olefination  with  (-)-48 under  KHMDS/DME condition  provided 
(+)-51. The coupling of Stannyl dienoate  52 with (+)-51 by using excess Ph2PO2NBu4 (12 
equiv) to suppress the E/Z isomerization and subsequent hydrolysis with LiOH in aqueous 
THF provided (Z,Z,E) trienoate (+)-53. Treatment of (+)-53 with TBSOTf (buffered with 
2,6-lutidine) transformed the tert-butylester groups to the TBS ether and exposure to 4N HCl 
in THF at room temperature for 24 h afforded (+)-sorangicin A which was identical in all re-
spect (1H, 13C, HRMS, HPLC, LRMS) to an authentic natural samples provided by the labor-
atory of G. Höfle et al.[14].     
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Scheme 10. First Total Synthesis of Sorangicin A
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1.5.2 Synthetic Efforts by Crimmins
Crimmins et al. reported[15] the construction of the C(29)-C(37) bicyclic ether by using the 
epoxy tosylate 65 (Scheme 11). The approach was designed around a three-step sequence of 
epoxide opening, epoxide formation and a second epoxide opening to afford the bicyclic 
fragment 66 from epoxide 65.
Scheme 11. Crimmins's Bicycles Synthesis        
The synthesis of the epoxide 65 was started with the known Evans anti-aldol reaction of  N-
propionylthiazolidinethione 55 and (E)-cinnamaldehyde  56, which delivered the aldol ad-
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aldehyde 58 was immediately subjected to Brown asymmetric allylation to afford the diol 60 
which was exposed to PPTS and 4-methoxybenzaldehyde dimethyl acetal to afford the  p-
methoxyphenyl acetal  61. Treatment of alkene  61 with two equivalent of ethyl acrylate in 
the presence of Grubb's second generation catalyst G2 at room temperature provided unsat-
urated ester 62. Reduction of ester 62 by exposure to i-Bu2AlH afforded allylic alcohol 63 
and subsequent Sharpless asymmetric epoxidation furnished epoxide 64. Epoxy alcohol 64 
was  treated  with  p-toluenesulfonyl  chloride  under  basic  condition  to yield  tosylate  65 
(Scheme 11). Treatment of the epoxide 65 successively by 10% HCl, 10% NaOH and 10% 
aqueous HCl in THF/MeOH in one-pot synthesis furnished bicyclic ether  66. Crimmins et  
al. developed a very efficient route to the bicyclic fragment 66 of (+)-sorangicin A with only 
nine steps and proceeds in good overall yield.
1.5.3 Synthetic Efforts by Lee 
The Lee laboratory group published[16] synthetic routes for the dihydropyran fragment with 
out the side chain using ring closing metathesis reaction to form the six membered ring. The 
synthesis of DHP fragment  74 started with known chiral alcohol  67 and alkylation of  67 
with bromoacetic acid in the presence of NaH furnished glycolic acid 68. Treatment of the 
glycolic acid 68 with pivaloyl chloride and use of the lithiated oxazolidinone provided 70. 
Treatment of the acylated oxazolidinone 70 with acrolein provided the hydroxyl compound 
71.  TBS-protection  of  the  resulting  secondary alcohol  71 and  subsequent  reductive 
elimination of the auxiliary afforded the primary alcohol 72. Olefinic ring closing metathesis 
reaction in the presence of Grubb's first generation catalyst  73 provided the desired DHP 
core 74. 
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Scheme 12. Lee's DHP Fragment Synthesis
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Chapter 2- Objective of Thesis Research
2.1 Objective
The objective of this work was to develop an efficient synthetic route to the C(1)-C(19) 
fragment of sorangicin with high yield and very good stereoselectivity (Scheme13).
Scheme 13. Retrosynthesis of Sorangicin  
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2.2 Synthesis of Fragment I and II
The  synthesis  of  fragment  I  and  fragment II  as  well  as  trials  to  the  synthesis  of  the 
dihydropyran fragment were reported[17], [18], [19] from our work group.
The  synthesis  of  fragment  I and  fragment  II was  reported  by  Claudia  Schulz[20].  The 
synthesis of both tetrahydropyran fragment  I and bicyclic ether fragment  II were accessed 
from one common intermediate.
The synthesis of the fragments started from propanediol 81 which was selectively protected 
and  oxidized  to  provide  TBS-protected  aldehyde  82 and  subsequent asymmetric  Brown 
crotylation gave homoallylic alcohol 84. Protection of 84 with TIPSOTf gave terminal olefin 
85 (Scheme  14). Dihydroxylation  of olefin 85 under  Sharpless  condition gave  two 
diastereomeric diols 86a and 86b. The syn,syn-diol 86a was able to afford the THP fragment 
I while the anti,syn-diol 86b gave the bicyclic fragment II. 
The  construction  of  the  THP  fragment  was  continued  by  protecting  diol 86a and 
deprotection of the TBS-ether and oxidation of the alcohol provided aldehyde 87. Selective 
Horners-Wadsworth-Emmons  olefination  and  1,2-reduction  gave  allylic  alcohol 88. 
Epoxidation of the internal olefin followed by protection of the alcohol with BnBr provided 
the epoxide 89 and subsequent acidic deprotection promoted the exo-cyclization to afford 
the THP fragment I.
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Scheme 14. Synthesis of Fragment I
For synthesizing the bicyclic fragment II the anti,syn-diol 86b was used. Protecting diol 86b 
and deprotection of the TBS-ether and subsequent oxidation of the alcohol gave  aldehyde 
90. Selective  Horners-Wadsworth-Emmons  olefination  and 1,2-reduction provided allylic 
alcohol 91. Epoxidation of the internal olefin followed by protection of the alcohol provided 
epoxide 92 and subsequent acidic deprotection promoted the Exo-cyclization to afford diol 
93. Protecting group manipulations prior to ultimate sulfonylation furnished mesylate 96
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and fragment  II. Selective cleavage of the PMB functionality of mesylate  96 with DDQ 
furnished alcohol 97 which was exposed to KHMDS to afford fragment II.
Scheme 15. Synthesis of Fragment II
Me
OTBS
OTIPSOH
OH
86b
1) p-TsOH, CuSO4
     acetone
2) TPAP, NMO
     2 steps, 78%
Me
CHO
OTIPSO
O
1) (CF3CH2O)2POCH2CO2CH3
    18-Crown-6
    KHMDS
2) iBu2AlH
     2 steps, 95%
Me
OTIPSO
O
1) D-DET
   Ti(Oi-Pr)4
    t-BuOOH, MS
2) BnBr, NaH
    Bu4NI
    2 steps, 68%
Me
OTIPSO
O
OBn
O
CSA
 82%
90
91 92
O
OTIPS
OH
OBn
OH
1) TIPSCl, Imidazole
     DMF
2) PMBCl, NaH, Bu4NI
     2 steps, 56%
O
OTIPS
OTIPS
OBn
OPMB
1) TBAF, THF
2) TIPSCl, Imidazole
     2 steps, 76%
O
OH
OTIPS
OBn
OPMB
 MsCl, Py
 DMAP
  96 (59%)
  II (28%)
O
OMs
OTIPS
OBn
OPMB +
O
O
OBnOTIPS
DDQ
 48%
O
OMs
OTIPS
OBn
OH
KH
M
DS
TH
F
  9
3%
93 94
95
96
97
II
OH
Theoretical Part                                                                                                                     24
2.3 Synthesis of the Dihydropyran Fragment 
The trial to the synthesis of the dihydropyran fragment was reported from our work group by 
Olga Krug[21]. The synthesis of the DHP subunit started with known conversion of glucose 
98 to tri-O-acetyl glucal which was reduced by basic methanol solution to afford glucal 99 
(Scheme  16). Subjection  of  the  glucal  to TMSOTf  followed  by  the  addition  of 
allyltrimethylsilane (ATMS) afforded diol  100.  The diols were protected with TBSCl and 
underwent Sharpless dihydroxylation, oxidative cleavage of the diols with NaIO4 as well as 
subsequent  deprotection  and protection  afforded alcohol  101. Compound 101 underwent 
swern oxidation, Grignard addition and DMP oxidation to afford methyl ketone  102. The 
synthesis of the side chain fragment started by coupling the known Seebach auxiliary  103 
with 6-heptenoyl chloride 104. Subsequent alkylation with MeI and reductive removal of the 
auxiliary with LAH resulted in alcohol  77. Treatment of 77 with Mitsunobu condition and 
subsequent oxidation gave the desired sulfone 105. The methyl ketone 102 and sulfone 105 
were coupled  using Julia-Kocienski  olefination  condition  to  afford  in  three  steps  the  Z- 
isomer acid 106.
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Scheme 16. DHP fragment Synthesis trial
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Chapter 3- Synthesis of Fragment D
3.1 Synthesis of L-hexoses
The synthesis of L-hexoses has been an interest for organic chemists for the past few dec-
ades. Many organic chemists have been trying to develop methods for synthesizing hexoses. 
The synthesis of L-hexoses involves the construction of four stereocenters with five similar 
hydroxyl groups. The hexoses are stereoisomers having a concatenation of four contiguous 
hydroxy-bearing carbogenic centers. Their enantio-controlled synthesis therefore requires a 
procedure leading to eight pairs of stereoisomers in enantio-and diastereo-controlled manner. 
3.1.1 Sharpless's Reiterative Two Carbon Extension Cycle
Sharpless et al.[22] described a systematic, stereoselective synthesis of all eight L-hexoses by 
a  synthetic  methodology  developed in  their  laboratories  for  the  preparation  of  polyhy-
droxylated natural products. Their strategy is based on the reiterative two-carbon extension 
cycle  (Scheme 17). It  consists  of four  steps,  (i)  conversion of  an  aldehyde into  its  corres-
ponding E-allylic alcohol, (ii) asymmetric epoxidation (AE) with titanium tetraisopropoxide, 
t-butylhydroperoxide, and (+) or (-) diethyl tartrate, (iii) treatment of the epoxy alcohol with 
benzenethiolate anion in a basic medium, (iv) oxidation and Pummerer reaction of the sulf-
ide followed by the net hydrolysis of the resulting gem-acetoxysulfide with or without inver-
sion of  the carbon center. The synthesis of the hexoses was accomplished in 14 synthetic 
steps and most of the reaction proceeding in a very good regio- and stereoselectivity.
Scheme 17. Sharpless's Synthesis of Hexoses
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3.1.2 Modifications to Sharpless's Strategy
Ogasawara et al.[23] reported an alternative to Sharpless route which required reiteration of 
two-carbon elongation and asymmetric epoxidation. They described a new strategy capable 
of producing all stereoisomers of L-hexoses from a single starting material employing an 
asymmetric chiral induction step (Scheme 18). 
Scheme 18. Ogasawara's Synthesis of L-Hexoses
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hydroxyl function by modification of the enone functionality. The most salient feature of the 
strategy is the use of the key intermediate 115 in two ways, namely the acetal carbon and the 
C-2 of the glycol carbons are placed at either the C-1 formyl functionality or the C-6  hy-
droxymethyl functionality of the target hexoses so as to produce the isomeric and/or the en-
antiomeric hexoses from the same precursor.
3.1.3 Hetero-Diels-Alder Reaction
Tietze  et  al.[24] reported  the  synthesis  of  sugars  using  hetero Diels-Alder  reactions.  The 
hetero Diels-Alder reactions of  130 with  132 was carried out using TMSOTf or Me2AlCl 
which  has  provided  in  a  very  good  yield  and  with  high  endo-selectivity  133.  The 
dihydropyran 133 was converted into carbohydrates in five step reaction sequences in a very 
good yield and high stereoselectivity (Scheme 19).
Scheme 19. Tietze's Synthesis of L-Hexoses
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zed by D-proline which was then followed by a tandem Mukaiyama aldol addition- cycliza-
tion step catalyzed by a Lewis acid. The initial step requires that the α-oxyaldehyde 137 par-
ticipate both as a nucleophile and an electrophile, whereas the product 138 must be inert for 
further aldol reactions. Mukaiyama aldol reaction of oxy-enolsilane 139 with TIPS- protec-
ted  β-oxyaldehyde  138 in the presence of a Lewis acid afforded the cyclization products, 
carbohydrate ring system (Scheme 20).  Exposure of the β-oxyaldehyde 138 and enolsilane 
139 to TiCl4 in CH2Cl2 affords high selectivity for allose 140a with a 97% yield and 19:1 se-
lectivity. The use of MgBr2.OEt2 in solvents such as Et2O, toluene or pentane shows prefer-
ence for glucose 140b with 8:1-10:1 selectivity. Using optimized condition, a 79% yield and 
a 10:1 preference for glucose in Et2O was obtained, whereas using MgBr2.OEt2  in CH2Cl2 
resulted in 87% yield and 19:1 selectivity for mannose 140c. 
Scheme 20. MacMillan's Synthesis of Hexose
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The aldehyde  142, was used both as nucleophile and electrophile, underwent dimerization 
using  D-proline/DMSO  condition  to  afford  TBS-protected  β-oxyaldehyde  143 in  76% 
(syn:anti, 1:3.4) yield (Scheme 21). 
Scheme 21. Synthesis of Oxyaldehyde
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Scheme 22. Synthesis of Oxy-enolsilane
TBS-protected β-oxyaldehyde 143 underwent Mukaiyama aldol reaction with oxy-enolsilane 
139 using MgBr2.Et2O/Et2O as a promoter to afford the intermediate oxocarbenium product 
147 which rapidly cyclized to afford the hexose fragment 148 in 75% yield. The treatment of 
148 with HBr/AcOH followed by Zn/AcOH furnished the TBS-protected glucal 149 in 60% 
yield[30] (Scheme 23).
Scheme 23. Synthesis of L-glucose Fragment
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HO OH Ac2O, Pyr
  86%
AcO OAc O3, CH2Cl2
 CH3OH, PPh3
   51%
AcO
O
Et3N, TMSCl
 CH3CN
   66%
AcO OTMS
144 145
146 139
AcO OTMS
139
O
OTBS
OH
OTBS
143
+
MgBr2-Et2O
 Et2O
  75%
OH
OTBS
OH
OTBS
OAc
O
O
OTBS
OH
AcO
HO
OTBS
HBr/AcOH
Zn/AcOH
   60%
147
148 149
O
OTBS
OH
OTBS
TMS
Theoretical Part                                                                                                                   32
Scheme 24. Modified Ferrier Reaction Trials
The modified Ferrier reaction of 150 with 152 was tested in a temperature ranging from -35 
°C to 25 °C as well as using different combination of Lewis acids and solvents (Table 1).
Lewis Acid Solvent Results
TiCl2 (OCH(CH3)2)2 CH2Cl2  No Reaction
TMSOTf CH2Cl2  No Reaction
BF3. OEt2 CH2Cl2  No Reaction
LiClO4 EtOAc  No Reaction
Table 1. Modified Ferrier Reaction  Results
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After testing the modified Ferrier reaction, our attention turned towards using the classical 
Ferrier reaction conditions by employing different precursors. Treatment of the TBS protec-
ted alcohol  149 with ATMS/TMSOTF furnished alkene 76 in 2 h, 91% yield and a very 
good selectivity as well as it shortened the overall synthetic route for the DHP fragment syn-
thesis. L-glucal 99 was treated with ATMS/TMSOTf to afford diol 100 in 84% yield[21]. Des-
pite the good yield, the synthesis of the L-glucal needed improvement as a result we tested 
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the tri-O-acetyl-L-glucal  150. The treatment of  150 with ATMS/TMSOTf afforded the di-
acetal alkene 154 in 96% and in a very good selectivity in 30 minutes[32] (Scheme 25).
Scheme 25. Classical Ferrier Reactions 
The diacetal alkene 154 was used for the next step with out any cleaning and reduction of 
154 with K2CO3/CH3OH afforded diol 100 in less than 1 h in 95% yield and it was used for 
the next step without any purification. Global silylation of 100 with TBSCl/Py afforded al-
kene 76 in 99% yield (Scheme 26). 
Scheme 26. Protection of the diols
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3.4 Oxidative Cleavage of the Terminal Double Bond 
3.4.1 Sharpless Asymmetric Dihydroxylation
The TBS-protected  alkene  76 was oxidized  using  Sharpless  reaction  condition[33].  Initial 
trial of oxidation using AD-mix-β in combination with t-BuOH/H2O (10:1) afforded the in-
termediate product  cis-diol  155 after 24 h of stirring. Oxidative cleavage of the diol with 
NaIO4 afforded the aldehyde 156 in a cumulative yield of 40%. Being discouraged by long 
reaction time, we employed[34] the use of catalytic amount of OsO4/NMO in combination 
with THF/H2O (1:1) which resulted in more clean intermediate cis-diol 155 in less than 5 h. 
Oxidative cleavage of diol 155 with NaIO4 afforded aldehyde 156 with a cumulative yield of 
61% (Scheme 27).
Scheme 27. Sharpless's Hydroxylation of the Terminal Alkenes
3.4.2 Ozonolysis
In  addition  to  Sharpless  dihydroxylation  method  we  tested  ozonolysis  as  well  as 
RuCl3/NaIO4/H2SO4 oxidation conditions[35]. Analysis of NMR spectra showed that the use of 
ozone resulted not only in the oxidation of the terminal double bond but it also resulted in 
the oxidation of the double bond on the ring. The use of the Ruthenium catalyzed oxidation 
did not work (Scheme 28).
Scheme 28. Oxidation of the Terminal Alkenes
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3.5 Protection of the Aldehyde 
3.5.1 Selective Protection of the Aldehyde 
The treatment of aldehyde  156 with HC(OMe)3 gave the protected alkene  157 which was 
subjected[36] to Camphorsulfonic acid (CSA) to afford alcohol 101 in a reaction time of 36 h 
and cumulative yield of 63% (Scheme 29). 
Scheme 29.  Selective Protection of the Aldehyde
3.5.2 Simultaneous Protection and Deprotection
After trying the two step protection and deprotection of aldehyde 156 with HC(OMe)3/CSA 
and being discouraged by long reaction time, we turned our attention to simultaneous protec-
tion and deprotection using molecular iodine in methanol solution[38]. The treatment of alde-
hyde 156 with CH3OH/I2  proceeded with deprotection of the primary TBS group providing 
the intermediate aldol 158 followed by protection of the aldehyde which afforded the alcohol 
101 in less than 5 h. This reaction gave a satisfactory yield of 70%, as well as proceeded 
with high selectivity in deprotecting the primary TBS exclusively (Scheme 30).   
Scheme 30. Simultaneous Protection and Deprotection
3.6 Completion of Fragment D
The alcohol 101 underwent Swern[39] oxidation using DMSO/(COCl)2 condition to afford the 
intermediate aldehyde  159 which was treated with MeMgBr/THF to afford methyl alcohol 
170 with a cumulative yield of 73% (Scheme 31). As an alternative to Swern condition, 
Dess-Martin oxidation[41]  of 101 afforded the intermediate aldehyde 159 in 95%  yield.
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Scheme 31. Grignard Reaction 
The methyl alcohol  160 was oxidized with Dess-Martin periodinane to afford the methyl 
ketone fragment 102 in 99% yield in less than 5 h. Because the stereochemistry at C-10 of 
sorangicin  A was  not  right[13],  classical  Mitsunobu inversion reaction  condition  was em-
ployed[43]. Deprotection of 102 with TBAF/THF afforded hydroxymethyl ketone 161 in 75% 
yield. The alcohol 161 was treated with  PPh3/DIAD/PNBA stirred overnight and reduced 
with K2CO3/CH3OH condition to afford the right configured hydroxy-methyl ketone 162 in 
65% cumulative yield. Protection of 162 with TBSCl/Py condition afforded fragment  D in 
85% yield (Scheme 32).
Scheme 32. Completion of Fragment  D
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3.7 Review of Synthetic Routes Tested
In developing a  synthetic  route for  fragment  D a  number  of  routes  as  well  as  different 
precursors were evaluated.  In these synthetic  routes we tested D-glucose,  L-glucose and 
ethylene glycol/cis-2-butenediol as a starting material.
 In our initial attempt D-glucose was used to test different reactions as well as develop new 
synthetic route for the DHP fragment synthesis as it is the cheaper isomer to test reactions. It 
was possible to change D-glucose 163 to the corresponding methyl ketone 171 in 8 reaction 
steps with an overall yield of more than 20% (Scheme 33). 
Scheme 33. D-glucose Synthetic Route 
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less than 6 reaction steps with an overall yield 25% and very good selectivity (Scheme 34).
Scheme 34. L-glucose Synthetic Route
In our third synthetic route tested, methyl ketone fragment  D was synthesized by starting 
from ethylene glycol/cis-2-butenediol in 12 reaction steps with an overall yield of more than 
17%. In this synthetic route it was possible to get the right stereochemistry at C-10 of soran-
gicin A as it has been discussed in the earlier part of this thesis (Scheme 35).
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Scheme 35. Ethylene Glycol Synthetic Route
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Chapter 4- Synthesis of Fragment E
4.1 Synthesis of Seebach Auxiliary 
The synthesis of the side chain fragment E started by synthesizing Seebach auxiliary 103 to 
insert the proper stereochemistry on the side chain fragment[44]. The Seebach auxiliary was 
synthesized by starting from D-valine 80 which was treated with thionyl chloride to afford 
the hydrochloride methyl ester 173 in 99% yield. The methyl ester hydrochloride 173 under-
went Grignard addition reaction using PhMgBr to afford the diphenyl alcohol  174 in 72% 
yield. Compound 174 was treated with acetyl chloride and triethylamine to afford the See-
bach auxiliary 103 in 52% yield (Scheme 36).
Scheme 36. Seebach Auxiliary Synthesis
4.2 Synthesis of (2R)-Methyl-hept-6-en-1-ol
The commercially available 6-heptenoic acid  175 was used as a starting material[21] in the 
synthesis of alcohol  77. The acid  175 was converted into a more reacting substance using 
oxalyl chloride to afford acyl-chloride 104 in 99% yield (Scheme 37). The acid chloride 104 
was coupled with Seebach auxiliary 103 in the presence of n-BuLi to afford the correspond-
ing diphenyl oxazolidinone 176 in 91% yield. The oxazolidinone 176 was treated with NaH-
MDS and underwent alkylation with MeI in high diasteroselectivity to afford the methyl-di-
phenyl oxazolidinone 177. Reductive removal of the Seebach auxiliary from 177 using LAH 
furnished methyl-hept-6-en-1-ol 77. 
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Scheme 37. Synthesis of (2R)-Methyl-hept-6-en-1-ol
4.3 Synthesis of (2R)-2-(2-Methylhept-6-en-1-sulfonyl)-1-phenyl-1H-   
       tetrazole
The modified Julia olefination[53] precursor fragment E synthesis was started by using the al-
cohol  77 which was converted to thiol  178 by employing the classical Mitsunobu reaction 
condition, PPh3/ DIAD/PTSH, in 92% yield. Sulfide 178 was converted to the corresponding 
sulfone fragment E in 63% yield using (NH4)6Mo7O24/H2O2 reaction condition (Scheme 38).
Scheme 38. Synthesis of Fragment  E
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4.4 Synthesis of (2R)-2-(2-Methylhept-6-en-1-sulfonyl)-Benzothiazole
The  synthesis  of benzothiazole 105 began with alcohol  77 which  was  converted  to  the 
corresponding thiol 179 using classical Mitsunobu reaction condition, PPh3/DIAD/BTSH, in 
90%  yield.  Compound  179 was  oxidized  to  the  corresponding  sulfone  using 
(NH4)6Mo7O24/H2O2  condition to afford sulfone 105 in 60% which was used as a precursor 
for the modified Julia olefination[49] (Scheme 39).       
Scheme 39. BT Sulfone Synthesis
4.5 Synthesis of (Hept-6-ene-1-sulfonyl)-benzene
In addition to synthesizing the precursors for modified Julia olefination we devised a new 
method for synthesizing the precursor for classical Julia olefination using one pot synthesis 
(Scheme 40). Treatment of hept-6-en-1-ol 180 with NBS/PPh3/THF and subsequent addition 
of ArSO2Na/NaI delivered phenyl sulfone 181 in 4 h with 72% yield[56]. The sulfone 8 can be 
used as a precursor in testing the classical Julia olefination.
Scheme 40. Classical Julia Precursor Synthesis
OH
77
PPh3, DIAD
BTSH, THF
  90% S
N
179
S
(NH4)6Mo7O24, H2O2
EtOH, 60%
S
N
105
S
O
O
OH
180
PPh3, NBS
THF, ArSO2Na
 NaI
 72%
S
O
O
181
Theoretical Part                                                                                                                     43
5 Coupling of the Fragments
5.1 Modern Olefination Methods
The  coupling  of  fragments  by  olefination  dates  back  to  first  olefination  of  carbonyl 
compounds by Georg Wittig back[65] in 1950 and he was awarded the Nobel prize for his 
pioneer work in 1960.  The olefination reaction has been an indispensable strategic tool in 
total synthesis as well in the construction of complex structure natural products for the last 
six decades. There are couple of strategies developed in the last four decades that allow 
synthesis of alkene with broad structural variety and functional group tolerance. The reaction 
of the carbanion being stabilized by leaving group (LG) that acts at the same time as good 
leaving group with aldehydes  or ketones.  Depending on the type of leaving group these 
transformation are known as Wittig reaction[66] (LG = PR3), Horner-Wittig[67] (LG = P(O)Ph2, 
Horner-Wadsworth-Emmons[68] (LG  =  P(O)(OR)2),  Julia  olefination[69] (LG  =  SO2R) or 
Peterson olefination[70] (LG = SiR3). In addition to these olefination methods, reactions were 
developed with direct or cross coupling of alkenes which includes Heck reaction [71] (Y = H) 
or with alkenyl metal Stille reaction[72] (Y = SnR3) or Negishi reaction[73] (Y = ZnR) by using 
appropriate  activated alkyl  subustrate  (Scheme 41).  The discovery of robust and readily 
availiable catalyst by Schrock[74] and Grubbs[75] made it also possible for synthesizing olefins 
through metathesis reactions.
Scheme 41. Olefination Methods
5.1.1 Wittig Olefination 
The  Wittig  reaction  is  one  of  the  most  reliable  reaction  for  the  synthesis  of  alkene.  It 
involves the use of phosphonium ylides which dates back to 1980s. Olefination occurs with 
complete regioseletivity where the carbonyl group of the substrate is replaced by alkene. 
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The currently accepted  mechanism for Wittig  olefination is  through the formation  of an 
intermediate phosphaoxetanes which stereospecifically collapse to give Z-or E-alkenes.
Scheme 42. Wittig Olefination
5.1.2 Horner-Wadsworth-Emmons Olefination 
An alternative to Wittig reaction was developed by Horner-Wadsworth-Emmons by using 
phosphonate instead of phosphonium ylides. The distinct difference between the two ylides 
is that the carbanion obtained upon deprotonation of the phosphonate are generally more 
reactive  than phosphonium ylides  so they need to  be stabilized  by electron withdrawing 
substituent in order to give useful ylides in a subsequent reaction with either aldehyde or 
ketone.  The stereoselectivity of HWE reaction can be controlled by steric and electronic 
properties of the alcohol group R2  in the phosphonate. A significant advantage of the HWE 
procedure is that the phosphorous by-product, the phosphoric acid salt, is water soluble and 
can be easily removed by aqueous work up unlike the Wittig olefination.
Scheme 43. Horner-Wadsworth-Emmons Olefination
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5.1.3 The Horner-Wittig Olefination 
Phosphine  oxide  is  another  class  of  phosphor  ylide  which  can  be  used  for  carbonyl 
olefination  for  a  reaction  that  is  commonly  referred  as  Horner-Wittig  reaction.  The 
mechanism is  similar  to  Wittig  and HWE but  the  important  difference  is  the  ability  to 
separate hydroxy phosphine oxides when lithium bases and low temperature are employed.
Scheme 44. Horner-Wittig Olefination
There are numerous examples of Wittig type of olefination in a natural product synthesis. A 
particular impressive example is the synthesis of the antibiotic aurodox by K. C. Nicolaou 
group[76].
Scheme 45. Wittig Type Olefination Reactions
5.1.4 The Peterson Olefination
Peterson olefination concept is similar to that of Wittig olefination, but it is quite different in 
scope and limitation  are alkenylations  that  proceed through  β-hydroxysilane.  It  involves 
alkene formation from carbanions stabilized by trialkylsilyl groups.  In this olefination an α-
silylated carbanion is added to a carbonyl compound to give rise to two diastereomeric  β-
hydroxysilane which can be isolated and transformed separately to alkene. Alkene formation 
from the β-hydroxysilane can occur by two different  mechanisms depending on whether 
acidic or basic condition are employed.
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Scheme 46. Peterson Olefination
5.1.5 Classical Julia Olefination 
The classical Julia[59] (Julia-Lythgoe) olefination was developed 40 years ago by Marc Julia 
and Jean-Marc Paris and it makes use of phenylsulfones. It has a high stereo-selectivity for 
trans-olefins,  but  the  classical  Julia  olefination  proceeds  with  four  different  synthetic 
operations[60],  metallation  of  a  phenylsulfone,  addition  of  the  metallate to  an  aldehyde, 
acylation of the resulting β-alkoxysulfone and reductive elimination of the β-acyloxysulfone 
with a single electron donor to afford alkene products. 
Scheme 47. Classical Julia Olefination
It has been reported[60] that isolation of the intermediate products is very essential to get a 
good yield from classical Julia olefination reactions unlike modified Julia olefination which 
proceeds only in a single reaction step.
5.1.6 Modified Julia Olefination
The modified Julia[49] (Julia-Kocienski) olefination was developed by Sylvestre Julia  et al. 
and  it  makes  use  of  hetero-arylsulfones.  The selectivity  of  modified  Julia  olefination  is 
affected by many factors including base, hetero-arylsulfone and structure of the substrate. 
The choice of hetero-arylsulfone affects selectivity as well as stereochemical outcome of the 
reaction. The different sulfone sources developed so far include benzothiazole (BT) , pyridin 
(PYR), phenyltetrazole (PT), tert-butyltetrazole (TBT). 
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Scheme 48. Modified Julia Sulfone Sources
The stereochemical  outcome of  the BT-variant  of modified  Julia  olefination  is  substrate 
controlled but it can also be influenced by controlling reaction conditions to synthesize the 
desired E:Z ratio of the product olefin. Generally PYR-sulfone give lower yields of trans- 
olefin products compared with BT-sulfones despite the stability of PYR-sulfone metallate. 
The PT-sulfone provides an alternative to the BT-sulfone and it has a higher level of trans- 
selectivity in the absence of biasing electronic or steric factors. Replacement of the phenyl 
moiety on the tetrazole ring in PT-sulfone improves the sulfone metallate stability, thus the 
bulk tert-butyl group in TBT-sulfone promotes high selectivity for cis-olefins.
5.2 Previous Efforts to Couple Fragments
The coupling of the fragments  started  by taking into consideration  the different  modern 
olefination  methods  discussed  in  the  previous  section  as  well  as  earlier  trials  to  couple 
fragments from our group[21]. There were efforts from our group to couple the dihydropyran 
fragment  102 and the side chain fragments 182, 183 using a Wittig type of reaction. The 
reactions were tested by employing different bases and solvents but none of the reaction 
tested resulted in triene 184 (Scheme 49).
Scheme 49. Wittig Coupling Trials
Due to discouraging result from Wittig reaction there were other attempts from our group[21] 
to  couple  the  fragments  by using modified  Julia  olefination  employing  BT-sulfone  105. 
Despite different combination of solvents and bases the reaction resulted only in Z-isomer 
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triene 185 (Scheme 50). 
Scheme 50. Modified Julia Coupling Trials
5.3 Coupling Strategies 
The construction of the C(1)-C(19) fragment started by synthesizing the three precursors, 
TIPS-protected  phenyltetrazole  sulfone  F,  methyl  ketone  D and  the  modified  Julia 
olefination precursor E. As a synthetic strategy we pursued to use modified Julia olefination 
conditions to construct C(7)-C(8) and C(15)-C(16) double bonds. We envisioned the first 
coupling  reaction  between  the  sulfone  fragment  F  and  aldehyde 156 followed  by 
deprotection,  Grignard addition,  oxidation,  inversion and finally a second modified  Julia 
olefination with sulfone fragment  E to complete the synthesis  of our target molecule  III 
(Scheme 51). We have pursued to couple the fragments using different coupling methods 
and reaction conditions. 
Scheme 51. Retrosynthesis of Target Molecule
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The TIPS-protected phenyltetrazole sulfone fragment F and the phosphonium salt 188 were 
synthesized in three steps from 1,4-butanediol  78. Selective protection of the diol  78 with 
NaH/TIPSCl  afforded  TIPS-protected  alcohol  75 in  82% which  was  converted  into  the 
corresponding  sulfone,  fragment  F,  or  phosphonium  salt  188 in  two  synthetic  steps. 
Mitsunobu  condition  reaction  of  75 followed  by  oxidation  with  (NH4)6Mo7O24/H2O2 
condition provided fragment F with a cumulative yield of 70% for two steps. Treatment of 
75 with  I2/Imidazole  condition  afforded  iodide  187 in  90%  which  was  subjected  to 
PPh3/CH3CN to afford phosphonium salt 188 in 69% (Scheme 52).
Scheme 52. Synthesis of Fragment F
In our initial attempt we pursued to couple fragment E with aldehyde 156 by using modified 
Julia olefination under barbier reaction conditions. The coupling reactions were tested by 
employing  different  combination  of  bases  and  solvents  but  none of  the  reactions  tested 
resulted in diene 189 (Scheme 53). 
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Scheme 53. Initial coupling trials I
After being discouraged by our initial attempts to couple the fragments using LiHMDS and 
NaHMDS we further tested the Julia olefination using KHMDS and LDA as well as the 
Wittig olefination which have resulted in the formation of the diene  190. First attempts to 
couple the fragment F with aldehyde 156 using KHMDS and LDA as bases resulted only in 
Z-isomer with 51% and 57% yields respectively. Further attempt to couple the phosphonium 
salt 188 with aldehyde 156 by employing Wittig reaction condition resulted also in Z-isomer 
diene 190 in 49% yield (Scheme 54).  
Scheme 54. Initial coupling trials II
After testing the initial coupling, we proceeded to evaluate different methods to couple the 
dihydropyran fragment  102 with the side chain fragment E. As it  has  been reported by 
Blakemore[60] phenyltetrazole sulfone and benzothiazole sulfone gives predominantly trans-
olefins  compared  with  the  other  sulfone  sources  developed so  far.  As a  result  coupling 
reactions were tested using sufone 191 or fragment E as well as benzothiazole sulfone 105.
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In addition to the type of sulfone source used, the order of addition of the substrates have 
been found to influence the outcome of the reaction as a result we tested both premetallate 
and barbier reaction conditions. Initially we tested premetallate condition, where the sulfone 
191 or fragment E and the base are added together to form the premetallate, followed by the 
addition  of  the  methyl  ketone  102 subsequently  to  the  reaction  mixture.  Different 
combination of bases and solvents were employed, but none of the reactions tested afforded 
triene 184 or 192 (Scheme 55). 
Scheme 55. Premetallate Conditions
After testing the premetallate condition, we further pursued to evaluate the barbier condition 
where the base was added to the mixture of the sulfone 191 or fragment E and methyl ketone 
102 which allows the metallate to react directly to the ketone reducing self-condensation of 
the sulfone.  Different combination of bases and solvents were evaluated, but none of the 
tested reactions resulted in triene 184 or 192 (Scheme 56). 
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Scheme 56. Barbier Conditions
In further attempt to couple the fragments, modfied Julia olefination reactions were tested by 
using  a  more  polar  aprotic  solvent,  DMPU,  in  combination  with  DMF  by  employing 
different  bases  and  using  barbier  olefination  condition.  The  phenyltetrazole  sulfone, 
fragment  E, and  benzothiazole  sulfone 105 were  used  as  a  Julia  olefination  precursors. 
Despite  the  different  combination  of  solvents  and  bases,  NMR  analysis  revealed  the 
presence of the coupling partners fragment E or 105 and 102 substantially (Scheme 57).
Scheme 57. Coupling trials with DMPU
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6. Summary and Outlook
6.1 Summary
This  work focused on the  synthesis  of  C(1)-C(19)  fragment  of  sorangicin  A as  well  as 
developing highly-selective and good yield synthetic routes for the synthesis of precursor 
fragments.
In the first part, we have evaluated different synthetic routes for the synthesis of fragment D 
by starting  from L-glucose.  We have improved the synthetic  route reported [21] from our 
group by reducing the reaction steps as well developing new reaction steps which are highly 
selective, proceed with very good yield and which resulted in more clean products. But the 
use of L-glucose as starting material was not feasible as a gram of L-glucose costs nearly 
100 Euro as a result we have developed a new synthetic route for synthesizing fragment D 
by starting from a commercially available cheap starting material, ethylene glycol  79 and 
cis-2-butenediol 144. It was possible to synthesize fragment D in less than 12 steps with an 
overall yield of more than 17%. 
Scheme 58. Synthesis of Fragment D
In the second part we have developed efficient synthetic route for synthesizing fragment E 
by starting  from D-valine 80 as  well  as  employing  reagents  which  are  less  toxic. The 
synthesis of Julia olefination precursors 191, fragment E and 105 were achieved in less than 
eight reaction steps and in an overall yield of more than 25%. In addition a new approach 
has been developed for synthesizing the precursor for classical Julia olefination.
Scheme 59. Synthesis of Fragment E
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In the final part of this work we tested different reaction conditions to couple fragment  D, 
fragment E  and  fragment  F.  A new  synthetic  route  approach  was  developed for  the 
construction of C(15)-C(16) double bond as well as a new approach has been developed for 
synthesizing the C(8)-C(19) fragments of sorangicin (Scheme 60).
Scheme 60. Coupling Trials
6.2 Future Direction
In the overall synthesis of the C(1)-C(19) fragment of sorangicin A there are still rooms for 
improvements as well as to develop new synthetic routes to couple the fragments.
In synthesizing fragment D, the route for synthesizing the L-glucose fragment can be further 
improved by employing substrates possessing the right protecting group and stereochemistry 
which  can  undergo  olefin  metathesis[16] to  afford  the  DHP  fragment  with  the  right 
stereochemistry at C-10 of sorangicin A. 
In synthesizing fragment E, heptenoic acid in combination with Seebach auxiliary were used 
as a starting material, it would be very reasonable to produce the intermediate alcohol 77 by 
starting from very cheap starting material as heptenoic acid is relatively expensive. 
In coupling the fragments by employing Julia olefination the following adjustments can be 
made in the future which could improve the coupling of the fragments as well as for the 
reaction to proceed with better selection for the trans-isomer.
HO OH
78
NN
N
N S
O
O OTIPS
F
O
OTBS
OTBS190
OTIPS
Future Direction                                                                                                        55
A. Introduction of strong polar aprotic solvents such as HMPA
The use of polar aprotic solvent such as HMPA in combination with THF, DME or DMF 
has been found[60] to improve the rate of coupling of the substrates as well as provides a 
higher selectivity for the trans-isomer. 
Scheme 61. Julia Olefination using aprotic solvents 
B. Using DHP Fragment as Julia Olefination precursor
         
The use of DHP or THP fragment as Julia olefination precursor instead of a side chain 
fragment has resulted [13], [60] in a better coupling results as well as gives higher selectivity for 
the  trans-isomer.  Thus it  could  be possible  to  couple  the fragments  by synthesizing  the 
aldehyde from the side chain fragment and the sulfone from the L-glucose fragment.
Scheme 62. DHP Fragment as Julia precursor  
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C. Employing Classical Julia Olefination 
It would be also possible to use the classical Julia olefination  by using the phenyl-sulfone 
199 and methyl-ketone 200 as a last alternative to couple the fragments as classical Julia 
olefination is known to give predominantly trans-isomer[59]  despite the need for four distinct 
synthetic operation.
Scheme 63.  Classical Julia Olefination. 
Based  on  the  different  synthetic  route  tested  and  experiments  done  in  this  work,  the 
synthesis of C(1)-C(28) fragments of sorangicin A can be easily achieved by using a simple 
operation of protection, deprotection and olefination (Scheme 66). Olefination of aldehyde 
156 with the phenyltetrazole sulfone fragment  F could afford diene 189 in four steps. The 
diene  189 will be coupled with the side chain fragment  E to give in three steps the triene 
fragment III.  Deprotection  of  the  TIPS  group  in  fragment III  followed  by  subsequent 
Mitsunobu reaction  and oxidation  will  afford  the  sulfone 200.  Metathesis  or  olefination 
between sulfone  200 and aldehyde 201 and subsequent deprotection manipulations could 
afford, 202, the C(1)-C(28) fragment of sorangicin A.
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Scheme 64.  Classical Julia Olefination. 
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7. Experimental Part
     7.1 Materials and Methods 
All reactions involving air-sensitive compounds were carried out under nitrogen by using 
oven-dried (90 °C) or flame dried glasses. 
The commercially available chemicals products were used without further purification or 
when appropriate were distilled before use. 
Tetrahydrofuran  (THF)  and  diethyl  ether  were  distilled  with  sodium/benzophenone  and 
dichloromethane (DCM) was distilled with calcium hydride absolutely under nitrogen before 
use  and  reaction  solvents  were  purified  according  to  standard  methods  or  dried  over 
molecular sieves before use. 
Preparative Column Chromatography 
Chromatographic purification of products (flash chromatography) was performed on E. Mer-
ck Silica Gel 60 (230-400 mesh) using a forced flow of eluant at 0.3-0.5 bar. 
Concentration under reduced pressure was performed by rotary evaporation at 40 °C at the 
appropriate pressure, unless otherwise stated.
Yields refer to chromatographically purified and spectroscopically pure compounds.
Nomenclature 
The compounds are named essentially according to IUPAC rules. The evaluation of the 
spectroscopic data used in quantifying the carbon centers was for reasons of clarity, and 
synthetic sequence is maintained.
Analysis 
For analytical thin-layer chromatography, TLC Cards PolyGram SIL G/UV254 with 
fluorescent indicator of the company Macherey & Nagel were used. The detection was 
carried out by irradiation with UV light (254 nm) and by immersing the developing TLC 
cards in vanillin, cerium (IV)-sulfate/phosphormolybdium acid or KMnO4 reagent followed 
by heating. 
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1H-NMR spectra were measured with Bruker using CDCl3 as a solvent. The chemical shifts 
are given in (δ, ppm), coupling constants (J, Hz) specified. For the signal-multiplicity the 
following abbreviations were used: s = singlet, d = doublet, t = triplet, q = quartet, m = 
multiplet, dd = double doublets, dt = double triplets, ddd = doublet of a doublets etc. 
13C-NMR spectra were measured with Bruker using CDCl3 as a solvent. To determine the 
signal-multiplicity DEPT-135-were used. The signal-multiplicities are as follows. q= CH3 
groups, t = CH2 groups, d = CH-group, s = quaternary C-atoms. 
Signal assignment is partly based on comparative data and analyzed using 
1
H, 
1
H-COSY, 
1
H, 
13
C-coupling experiments and NOESY experiments.
Mass Spectra was measured with a Finnigan SSQ 7000 mass spectrometer. The relative 
intensities are in [%] relative to the Base peak (100%) indicated. Ionization method was used 
with CH4 as a reactant gas.
High Resolution Mass Spectrometry (HRMS) were measured with a Finnigan MAT 95 
mass spectrometer after escan methods. 
IR Spectra were measured with a Perkin-Elmer FT-IR-2000-spectrometer. The spectra of 
liquids were measured as a thin film on KBr discs with an IR microscope. The position of 
the absorption bands are indicated in wave numbers ν [cm-1]. The relative band intensities 
are abbreviated as follows: w = weak, m = medium, s = strong, b = broad signal.
UV / VIS Spectra were measured with a Perkin-Elmer Lambda 19 spectrometer.
Specific Rotation values were measured with a Perkin-Elmer 341-polarimeter. The specific 
rotation value (α) is given in (10
2
deg kg
-1
m
-2
) at 25 °C and the concentration. 
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Coloring agents for Thin-Layer Chromatography 
a) Vanillin Reagent:- Dissolve 8.6 g of vanillin in 200 ml of ethanol and add slowly  
     2.5 ml of sulfuric acid
b) Cerium (IV)-Sulfate/Phosphomolybdic acid: - Slowly add 16 ml of concentrated   
     sulfuric acid to 5 g of Phosphomolybdic acid in 200 ml of water and 2 g of 
     cerium (IV)-sulfate. 
c) Potassium Permanganate:-  Slowly add 5 ml of 5% caustic soda to a mixture of 3 g  
     KMnO4 and 20 g K2CO3 in 300 ml water. 
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D-Valine-hydrochloride-methylester (173)
D-valine (10 g, 85.4 mmol) was dissolved in methanol (100 ml), cooled to 0 °C and thionyl 
chloride (15 g, 126 mmol) was added dropwise over a period of 30 minutes [44]. The reaction 
mixture was warmed up to room temperature, stirred for 24 h and volatiles were removed in 
vacuo to afford a white crystalline product 173 (14.3 g, 85 mmol, 99%). 
General Data:                                         C6H14ClNO2, M = 167.63 g/mol, white solid; 
                                                                   Rf  = 0.1 (100% EtOAc); UV (+); Vanillin (-);
1H-NMR (400 MHz, CDCl3, δ ppm)      δ = 4.82 (s, H-6, 3H); 3.88 (d, 4.7 Hz, H-2, 1H); 
                                                                   2.40 (m, H-3, 1H); 1.08 (d, 5.7 Hz, H-4, 3H); 
                                                                   1.07 (d, 5.4 Hz, H-5, 3H);       
13C-NMR (100MHz, CDCl3, δ ppm)      δ = 172.48 (C-1), 60.54 (C-2), 55.58 (C-6), 31.44 
                                                                   (C-3), 19.47 (C-4), 19.20 (C-5);
MS (EI)                                                 167.1 (5%), 149.1 (36%), 131.2 (28%), 88.1 (85%)
                                                                   74.0 (16%), 72.1 (100%), 55.1 (100%);        
IR (Cap. Film)                                        3431 (br), 2968 (s), 1942 (s), 1586 (s), 1437 (s),
                                                                   1334 (s), 1294 (s);                  
HRMS                                                  C6H14 ClNO2
                                                              Calcd: 167.070
                                                            Found: 167.075
O
O
NH3Cl1
2
34
5
6
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2-Amino-3-methyl-1,1-diphenyl-butane-1-ol (174)
To  a  freshly  prepared  solution  of  PhMgBr  (45  g,  248  mmol)  in  abs.  Et2O  (150  ml) 
compound 173 (14.3 g, 85.3 mmol) was added dropwise[44]. The reaction mixture was stirred 
at room temperature for 30 minutes and further refluxed for 24 h. The reaction was cooled to 
room temperature quenched by adding ice cold water and treated with HCl (1N) and EtOAc 
(110  ml)  consecutively. The  reaction  mixture  was  brought  to  pH=5 by using  ammonia 
solution and the water phase was extracted with Et2O (3 x 50 ml). Methanol (5 ml) was 
added to the solution and the combined organic layer was dried over MgSO4. The volatiles 
were concentrated in vacuo to afford the alcohol 174 (15.7 g, 61.5 mmol, 72%). 
General Data:                                       C17H21NO, M = 255.35 g/mol, yellowish solid; 
                                                                  Rf  = 0.53 (100% EtOAc); UV (+); Vanillin (-);
1H-NMR (400 MHz, CDCl3, δ ppm)     δ = 7.62-7.12 (m, Ph, 10H); 3.83 (m, H-2, 1H); 2.5 
                                                                  (m, H-3, 1H); 0.92 (d, 7.0 Hz, H-4, 3H); 0.89 (d, 
                                                                  7.0 Hz, H-5, 3H);                                                 
13C-NMR (100MHz, CDCl3, δ ppm)     δ = 147. 85 (Ph), 144.80 (Ph), 128.33 (Ph), 127.95
                                                                  (Ph), 126.52 (Ph), 126.19 (Ph), 125.82 (Ph), 125.3 
                                                                  (Ph), 79.64 (C-1),  60.11 (C-2), 27.75 (C-3), 22.91 
                                                                  (C-4), 16.05 (C-5);   
MS (EI)                                                 255.3 (15%), 238.3 (28%), 212.2 (24%), 195.2   
                                                                  (68%), 183.2 (64%), 165.2 (68%), 105.1 (92%),
                                                                  72.2 (100%), 55.1(82%);    
Ph
HO
H NH2
Ph1
2 3
4
5
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IR (Cap. Film)                                       3900 (m), 3817(s), 2964 (s), 1739 (s), 1661 (s)
                                                                  1595 (s), 1490 (s), 704 (s), 639 (s); 
4(R)-Isopropyl-5, 5-diphenyl-oxazolidin-2-one (103)
To a solution of alcohol 174 (3.15 g, 12.35 mmol) in abs. CH2Cl2 (63 ml) and Et3N (1.9 ml, 
13.6 mmol) cooled to -25 °C was added acetyl chloride (1.9 ml, 24.7 mmol) [44]. The reaction 
was warmed up to room temperature and was stirred for 24 h. The reaction mixture was 
treated with HCl (1N) and the volatiles were removed in vacuo. The remaining solution was 
treated with 1N NaOH in CH3OH (150 ml)  and was refluxed for 9 h. The reaction was 
diluted  with  water,  cooled  to  0  °C  and  the  solid  residue  was  washed  with  H2O,  Et2O 
(1ml/mmol) and pentane consecutively to afford auxiliary 103 (1.8 g, 6.4 mmol, 52%). 
General Data:                                         C18H19NO2, M = 281.35 g/mol, White solid; 
                                                                   Rf = 0.55 (100% EtOAc); UV (+); Vanillin (-); 
1H-NMR (400 MHz, CDCl3, δ ppm)    δ = 7.56-7.54 (m, 2H, Ph); 7.40-7.27 (m, 8H, Ph)
                                                                   6.17 (br, 1H, NH); 4.36 (d, 3.6 Hz, H-4, 1H);
                                                                   1.90-1.86 (m, H-6, 1H); 0.90 (d, 7.0 Hz, H-8, 3H)
                                                                   0.70 (d, 6.8 Hz, H-7, 3H);
13C-NMR (100MHz, CDCl3, δ ppm)      δ = 158.47 (C-2), 143.84 (Ph), 139.10 (Ph), 128.51 
                                                                  (Ph), 128.19 (Ph), 128.06 (Ph), 127.67 (Ph), 126.28
                                                                  (Ph), 125.66 (Ph), 89.32 (C-5), 65.77 (C-4), 29.54 
O NH
O
Ph
Ph
2
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                                                        (C-6), 20.82 (C-8), 15.56 (C-7);
MS (EI)                                                 281.3 (8%), 261.3 (4%), 238.2 (3%), 194.3 (20%),
                                                                  183.2 (100%), 165.2 (16%), 105.1 (24%), 77.1
                                                                  (8%);   
IR (Cap. Film)                                       3294 (s), 2982 (s), 1765 (s), 1745 (s), 1468 (s),
                                                                  1452 (s), 1393 (s), 1316 (s), 1252 (s), 708 (s);
HRMS                                                  C18H19NO2
                                                                  Calcd: 281.140
                                                                  Found: 281.142
Hept-6-enoylchloride (104)
To a solution of 6-heptenoic acid 175 (2.6 g, 20.3 mmol) in CH2Cl2 (10 ml) was added oxalyl 
chloride (5.15 g, 40.6 mmol) and the reaction was stirred for 1 h at room temperature and 
refluxed at 40 °C for 1 h[21]. Volatiles were removed in vacuo to afford the acid chloride 104 
(2.97 g, 20.2 mmol, 99%). 
General Data:                                      C7H11ClO, M = 146.62 g/mol, colorless oil;
                                                                    Rf = 0.64 (100% EtOAc); Vanillin: blue, UV (-);
1H-NMR  (400 MHz, CDCl3, δ ppm)    δ = 5.86-5.66 (m, H-6, 1H), 5.06-4.92 (m, H-7,
                                                                    2H); 2.88 (m, H-2, 2H); 2.55-2.01 (m, H-5, 2H);
                                                                    1.52-1.36 (m, H-3, H-4, 4H);
13C-NMR (100MHz, CDCl3, δ ppm)       δ = 173.64 (C-1), 137.75 (C-6), 115.12 (C-7),
                                                                   46.87 (C-2), 33.05 (C-5), 27.52 (C-3), 24.41 (C-4);
Cl
O
1
2
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3'-Hept-6-enoyl-4'(R)-isopropyl-5',5'-diphenyl-oxazolidin-2'-one (176)
To a solution of the auxiliary 103 (856 mg, 3.0 mmol) in THF (5 ml) cooled to 0 °C was 
added n-BuLi (2.22 ml, 3.45 mmol, 1.6 M in Hexane). To the resulting clear solution was 
added acid chloride 104 (558 mg, 3.81 mmol) in one portion[21]. The reaction was stirred for 
24 h and quenched with saturated aqueous NaHCO3 and the water phase was extracted with 
Et2O (4 x 25 ml). The organic phase was washed successively with HCl (1M), NaOH (1M) 
and saturated aqueous NaCl. The organic phase was dried over Na2SO4 and volatiles were 
removed in vacuo and residue was purified by flash chromatography with Pentane:Ether 
(5:1) to afford 176 (1.07 g, 2.73 mmol, 91%).
General Data:                                       C25H29NO3, M = 391.50 g/mol, yellowish oil;
                                                                    Rf = 0.69 (100% EtOAc); UV (+);
                                                                    [α]20 = +179.0° (c = 1.30 CHCl3); Vanillin: rose;
1H-NMR (400 MHz, CDCl3, δ ppm)     δ = 7.49-7.25 (m, Ph, 10H); 5.79 (m, H-6, 1H);
                                                                    5.37 (d, 3.4 Hz, H-4', 1H); 4.99 (m, H-7, 2H); 
                                                                    2.91-2.72 (ddd, 16 Hz, 8.2 Hz, 6.7 Hz, H-2, 2H); 
                                                                    2.07-1.93 (m, H-5, H-1'', 3H); 1.66-1.28 (m, 
                                                                    H-3, H-4, 4H); 0.88 (d, 7.0 Hz, H-3'', 3H); 0.77 
                                                                    (d, 6.8 Hz, H-2'', 3H); 
13C-NMR (100MHz, CDCl3, δ ppm)       δ = 173.05 (C-1), 153.03 (C-2'), 142.37 (Ph),  
                                                                    138.39 (C-6), 138.17 (Ph), 128.86 (Ph), 128.54 
                                                                    (Ph), 128.35 (Ph), 127.91 (Ph),  125.91 (Ph), 
                                                                    125.60 (Ph), 114.58 (C-7), 89.33 (C-5'), 64.49
O N
O
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Ph
O
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                                                                    (C-4'), 34.95 (C-2), 33.35 (C-5), 29.83 (C-3), 
                                                                    28.12 (C-1''),  24.07 (C-4), 21.75 (C-3''), 16.40 
                                                                    (C-2'');
MS (EI)                                                  391.5 (100%), 355.3 (28%), 348.4 (68%), 169.3
                                                                    (60%), 143.3 (100%), 85.2 (69), 57.1 (24);
 IR (Cap. Film)                                        3064 (br), 2968 (s), 2934 (s), 2877 (br), 1785 (s),
                                                                    1706 (s), 1450 (s), 1364 (s), 1318 (s), 1210 (s),
                                                                    1175 (s), 761 (s), 704 (s);
HRMS                                                   C25H29NO3
                                                                   Calcd: 391.214
                                                                   Found: 391.215
(2R,4'R)-Isopropyl-3'-(2-methyl-hept-6-enoyl)-5',5'-diphenyl-oxazolidin-
2'-one (177)
To a solution  of  176 (2.0 g,  5.11 mmol)  in  THF (27 ml)  cooled  to  -78 °C was added 
NaHMDS (6.01 ml, 6.01 mmol, 1.0 M in THF). After stirring it for 1 h, CH3I (1.0 g, 7.05 
mmol) was added and the reaction was allowed to warm up slowly to room temperature and 
was stirred for 24 h[21]. The reaction was quenched with saturated aqueous NH4Cl and the 
water phase was extracted with Et2O (4 x 50 ml) and the combined organic phase was dried 
over MgSO4.  The volatiles were removed in vacuo and the residue was purified by flash 
chromatography with Pentane:Ether (10:1) to afford 177 (1.52 g, 3.75 mmol, 74%).
O N
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General Data:                                     C26H31NO3, M = 405.53 g/mol, yellowish oil;
                                                                      Rf = 0.70 (100% EtOAc); UV (+); Vanillin: rose;
                                                                   [α]20 = +139.1° (c = 1.05 CHCl3);
1H-NMR (400 MHz, CDCl3, δ ppm)      δ = 7.58-7.22 (m, Ph, 10H); 5.61-5.51 (m, H-6,
                                                                   1H); 5.38 (d, 3.5 Hz, H-4', 1H); 4.86-4.81 (m, H-7,
                                                                   2H); 3.66 (m, H-2, 1H); 2.01 (m, H-1'', 1H); 1.78-
                                                                   1.72 (m, H-5, 2H); 1.56-1.41 (m, H-3, 2H); 1.20
                                                                   (d, 6.8 Hz, H-8, 3H); 1.07-1.05 (m, H-4, 2H); 0.87
                                                                   (d, 7.0 Hz, H-2''); 0.77 (d, 6.7 Hz, H-3'', 3H); 
13C-NMR(100MHz, CDCl3, δ ppm)        δ = 176.75 (C-1), 152.88 (C-2'), 142.31 (Ph),  
                                                                   138.19 (C-6), 137.96 (Ph), 128.70 (Ph), 128.43 
                                                                   (Ph), 128.37 (Ph), 127.91 (Ph), 125.86 (Ph), 
                                                                   125.56 (Ph), 114.34 (C-7), 89.12 (C-5'), 64.55
                                                                   (C-4'), 36.98 (C-2), 33.37 (C-5), 32.70 (C-3),
                                                                   29.62 (C-1''), 25.75 (C-4), 21.57 (C-8), 17.84 
                                                                   (C-3''), 16.29 (C-2'');
MS (EI)                                                  405.2 (5%), 337.2 (21%), 238.1 (13%),  220.1
                                                                   (50%), 125.1 (48), 97.1 (46%), 77.0 (100%), 
                                                                   55.0 (79%);
IR (Cap. Film)                                          3392 (b), 2968 (s), 2935 (s), 1786 (s), 1703 (s),
                                                                   1451 (s),  1385 (s), 1363 (s), 1317 (m), 1210 
                                                                   (m), 761 (s), 705 (s);
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HRMS                                                  C26H31NO3
                                                            Calcd: 405.230
                                                            Found: 405.227
(2R)-Methyl-hept-6-en-1-ol (77)
To a 0 °C cooled solution of 177 (1.55 g, 3.71 mmol) in Et2O (25 ml), was added LAH (1.15 
g, 30.23 mmol). The reaction was refluxed for 2 h and then cooled to room temperature and 
quenched with water[21]. The reaction was filtered over celite and extracted with Et2O (8 x 50 
ml).  The  volatiles  were  removed  in  vacuo  and  the  residue  was  purified  by  flash 
chromatography with Pentane:Ether (3:1) to afford alcohol 77 (0.45 g, 3.52 mmol, 96%).
General Data:                                           C8H16O, M = 128.21 g/mol, colorless liquid;
                                                                         [α]20 = + 19.1 (c = 1.00CHCl3); UV(-);
                                                                         Rf  = 0.5 (100% EtOAc); Vanillin: Violet;
1H-NMR (400 MHz, CDCl3, δ ppm)            δ = 5.79-5.76 (m, H-6, 1H); 5.03-4.93 (m, H-7,
                                                                         2H); 3.41 (m, H-1, 2H); 2.07-2.03 (m, H-5,
                                                                         2H); 1.65-1.42 (m, H-2, H-3, H-4, 5H); 1.02
                                                                         (d, 6.6 Hz, H-8, 3H); 
13C-NMR (100MHz, CDCl3, δ ppm)            δ = 138.91 (C-7), 114.39 (C-6), 68.31 (C-1), 
                                                                         35.66 (C-2), 34.11 (C-5), 32.60 (C-3), 26.29
                                                                         (C-4), 16.52 (C-8);
MS (EI):                                                          130.1 (8%), 128.1 (15%), 110 (9%),  97 (12%)
                                                                         81.1 (44%), 71.1 (28%), 69.1 (34%), 67.1 (35),
OH
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                                                                         56.1 (33%), 55.0 (100%), 43.1 (20%);
IR (Cap. Film):                                                3351 (b), 2931 (s), 2879 (s), 1644 (s), 1468
                                                                         (s), 1379 (s), 1039 (s), 910 (s);
HRMS                                                             C8H16O
                                                                         Calcd: 128.120
                                                                         Found: 128.109
(Hept-6-en-1-sulfonyl)-benzene (181)
To a stirred solution of  the hept-6-en-1-ol 180 (50 mg, 0.39 mmol) and PPh3  (419 mg, 1.6 
mmol) in THF (5 ml) under N2 was added NBS (315 mg, 1.6 mmol) in small portion over 15 
minutes and the reaction was stirred further for 30 minutes[56]. To the reaction was added 
ArSO2Na (360 mg, 2.0 mmol) and NaI (15 mg, 0.1 mmol) in three portions over 10 minutes 
and was stirred for 4 h. The reaction was diluted with EtOAc (10 ml)  and 3% aqueous 
solution Na2S2O3 (10 ml).  The organic phase was separated  and the aqueous phase was 
extracted with EtOAc (4 x 50 ml) and the organic phase was successively washed with H 2O, 
brine and dried over Na2SO4.  The volatiles  were removed in vacuo and the residue was 
purified by flash chromatography with Hexane:EtOAc (9:1) to afford sulfone 181 (70.6 mg, 
0.28 mmol, 72%).
General Data:                                          C13H18O2S, M = 238.35 g/mol, yellowish oil;
                                                                    Rf = 0.61 (100% EtOAc); UV (+); Vanillin: blue; 
1H-NMR (400 MHz, CDCl3, δ ppm)       δ = 7.92-7.89 (m, Ph, 2H); 7.72-7.55 (m, Ph, 3H);
                                                                    5.79 (m, H-6, 1H); 4.98-4.91 (m, H-7, 2H); 3.49- 
                                                                    3.10 (m, H-1, 2H); 2.07-1.93 (m, H-5, 2H); 1.76-
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                                                                    1.51 (m, H-2, 2H); 1.38-1.20 (m, H-3, H-4, 4H); 
13C-NMR (100MHz, CDCl3, δ ppm)        δ = 144.73 (Ph), 138.61 (C-7), 132.01 (Ph),128.9
                                                                    (Ph), 125.22 (Ph), 114.49 (C-6), 64.66 (C-1),
                                                                    33.50 (C-5), 29.51 (C-2), 28.31 (C-3), 25.15
                                                                    (C-4);       
MS (EI)                                                       238.1 (5%), 218.0 (15%), 143 (38%), 125 (35%),
                                                                    97.1 (45%), 77.1 (25%), 55.0 (100%); 
IR (Cap. Film)                                           3469 (br), 3065 (s), 2930 (m), 2857 (s), 1959 (s)
                                                                    1640 (s), 1462 (s), 1383 (s),  1306 (s), 1135 (s)
                                                                    753 (s), 698 (s), 595 (s), 564 (s), 536 (s).   
HRMS                                                       C13H18O2S  
                                                                    Calcld: 238.100
                                                                    Found: 238.103
5'-(Hept-6-enylsulfanyl)-1'-phenyl-1H-tetrazole (203)
A solution of the hept-6-en-1-ol (31 mg, 0.27 mmol), 1-phenyl-1H-tetrazole-5-thiol (28 mg, 
0.44 mmol) and PPh3  (114 mg, 0.44 mmol) in THF (2.5 ml) was cooled to 0 °C. After 45 
minutes of stirring DIAD (88 mg, 0.44 mmol, 86 µl) was added, reaction was allowed to 
warm up to room temperature and stirred for 4 h. The volatiles were removed in vacuo and 
the residue was dissolved in Et2O (20 ml) and was kept for 4 h at -20 °C. The precipitated 
OPPh3 was removed by filtration and Et2O was removed in vacuo. The residue was purified 
by flash chromatography with Pentane:Ether (10:1) to afford 203 (61 mg, 0.22 mmol, 82%).
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General Data:                                          C14H18SN4, M = 274.39 g/mol, yellowish oil;
                                                                    Rf = 0.56 (Pe/Et2O 10:1); UV (+); Vanillin: blue; 
1H-NMR (400 MHz, CDCl3, δ ppm)       δ = 7.51-7.27 (m, H-2'', H-3'', H-4'', H-5'', H-6'', 
                                                                   5H); 5.79 (ddt, 6.7 Hz, 10.2 Hz, 17.0 Hz, 1H, H-6)
                                                                    5.01-4.92 (m, H-7, 2H); 3.39 (dd, 14.8 Hz, 7.4 Hz
                                                                    H-1, 2H); 2.08-2.03 (m, H-5, 2H); 1.87-1.77 (m,
                                                                    H-2,  2H); 1.55-1.40 (m, H-4, H-3, 4H);
13C-NMR (100MHz, CDCl3, δ ppm)        δ = 154.38 (C-5''), 138.44 (C-6), 133.68 (C-1''),
                                                                     129.99 (C-2'', C-6''), 129.69 (C-4''), 123.77 (C-3'',
                                                                     C-5''), 114.56 (C-7), 33.40 (C-1), 33.20 (C-5),
                                                                      28.86 (C-2), 28.15 (C-3), 27.96 (C-4); 
 MS (EI)                                                       274.1 (5%), 241.1 (55%), 227.1 (10%), 213 
                                                                     (12%), 199.1 (15%), 165 (100%), 104 (100%);
IR (Cap. Film)                                            1959 (s), 1885 (s), 1809 (s), 1641 (s), 1596 (s),
                                                                     1498 (s), 1462 (s), 1342 (br), 1153 (s), 1077 (m), 
                                                                       914 (s), 726 (s), 544 (s). 
HRMS                                                       C14H18SN4 
                                                                    Calcld: 274.130
                                                                    Found: 274.141
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5'-(Hept-6-ene-1-sulfonyl)-1'-phenyl-1H-tetrazole (191)
The prepared sulfide 203 (29 mg, 0.11 mmol) was dissolved in EtOH (3.2 ml), cooled to 0 
°C and a premixed, bright yellow solution of (NH4)6Mo7O24 (5.12 mg, 0.022 mmol) in 35% 
aqueous  solution  of  H2O2 (5.34  ml,  5.5  mmol)  was  added  slowly  over  5  minutes.  The 
reaction was allowed to warm up to room temperature and stirred for 6 h. A mixture of 
EtOAc:H2O (1:1) (10 ml) was added and the layers were separated. The aqueous layer was 
extracted with EtOAc (3 x 15 ml) and the combined organic layer was washed with H2O (5 
ml),  brine (50 ml), and dried over MgSO4. The solvents were removed in vacuo and the 
residue was purified by flash chromatography with Pentane:Ether (10:1) to afford sulfone 
191 (48 mg, 0.029 mmol, 65%).     
General Data:                                       C14H18N4O2S, M = 306.38 g/mol, yellowish oil; 
                                                                 Rf = 0.50 (Pe/Et2O, 10:1); UV (+); Vanillin: blue;
1H-NMR (400 MHz, CDCl3, δ ppm)    δ = 7.61-7.52 (m, H-2'', H-3'', H-4'', H-5'', H-6'', 
                                                                 5H); 5.79 (ddt, 6.7 Hz,10.2 Hz, 17.0 Hz, H-6, 1H); 
                                                                 5.02-4.95 (m, H-7, 2H); 3.75-3.72 (dd, 16.1 Hz,
                                                                 7.2 Hz, H-1, 2H); 2.08 (d, 8.1 Hz, H-5, 2H); 1.98-
                                                                 1.94 (m, H-2, 2H); 1.53-1.44 (m, H-4, H-3, 4H);   
13C-NMR (100MHz, CDCl3, δ ppm)    δ = 153.42 (C-5'), 138.04 (C-6), 132.99 (C-1''),
                                                                131.43 (C-2'', C-6''), 129.68 (C-4''), 125.02 (C-3'',  
                                                                C-5''), 114.97 (C-7), 55.88 (C-1), 33.17 (C-5), 29.65
                                                                (C-2), 28.03  (C-3), 27.47 (C-4);
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MS (EI)                                                  307.1 (5%), 277.1 (55%), 258.1 (10%), 213 (12%),
                                                                163.1 (15%), 118.1 (100%), 91.0 (18%), 77.0 (18%),
                                                                55.0 (65%);
IR (Cap. Film)                                       3462 (br), 3075 (s), 2928 (m), 2858 (s), 2486 (s),
                                                                1959 (s), 1885 (s), 1809 (s), 1641 (s), 1596 (s), 1498 
                                                                (s), 1462 (s), 1342 (br), 1153 (s), 1077 (m), 914 (s),
                                                                726 (s), 544 (s); 
HRMS                                                  C14H18N4O2S
                                                                Calcld: 306.120
                                                                Found: 306.115
5'-(2(R)-Methyl-hept-6-enylsulfanyl)-1'-phenyl-1H-tetrazole (178)
A solution of the alcohol 77 (31 mg, 0.24 mmol), 1-phenyl-1H-tetrazole-5-thiol (28 mg, 0.44 
mmol) and PPh3 (114 mg, 0.44 mmol) in THF (2.5 ml) was cooled to 0 °C. After 45 minutes 
of stirring DIAD (88 mg, 0.44 mmol, 0.086 ml) was added and reaction was allowed to 
warm up to room temperature and stirred for 4 h. The volatiles were removed in vacuo and 
the residue was dissolved in Et2O (20 ml) and was kept for 4 h at -20 °C. The precipitated 
OPPh3 was removed by filtration and Et2O was removed in vacuo. The residue was purified 
by flash chromatography with Pentane:Ether (10:1) to afford sulfide 178 (61 mg, 0.22 mmol, 
92%). 
General Data:                                                   C15H20SN4, M = 288.41 g/mol, yellowish oil; 
                                                                             Rf = 0.85 (100% EtOAc); Vanillin: blue;
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                                                                             [α]20 = -3.1° (c = 1.03 CHCl3); UV (+);
1H-NMR (400 MHz, CDCl3, δ ppm)                δ = 7.60-7.51 (m, H-2'', H-3'', H-4'', H-5'', H- 
                                                                             6'', 5H); 5.79 (ddt, 6.8 Hz, 10.4 Hz, 17.1 Hz
                                                                             H-6, 1H); 5.01-4.95 (m, H-7, 2H); 3.48-3.23 
                                                                            (dd, 12.6 Hz, 7.5Hz, H-1, 2H); 2.06 (dd, 13.2
                                                                             Hz, 6.5 Hz, H-5, 2H); 1.99 (d, 6.5 Hz, H-2,
                                                                             1H); 1.55-1.19 (m, H-3, H-4, 4H); 1.04 (d,
                                                                             6.7 Hz, H-1''', 3H); 
13C-NMR (100MHz, CDCl3, δ ppm)                δ = 154.69 (C-5'), 138.54 (C-6), 133.72 
                                                                             (C-1''), 130.04 (C-2'', C-6''), 129.74 (C-4''),  
                                                                             123.86  (C-3'', C-5''), 114.63 (C-7), 40.42 
                                                                             (C-1), 35.28 (C-3), 33.73 (C-5), 32.80 (C-2), 
                                                                             26.05 (C-4), 19.06 (C-1'''); 
MS (EI)                                                               288.1 (8%), 255.1 (52%), 227.1 (6%), 179.2
                                                                             (96%), 150.2 (52%), 143.1 (60%), 118.2 
                                                                             (100%), 101 (45%), 91.1 (28%), 77.1 (40%)
                                                                             69 (36%), 55.1 (58%);
IR (Cap. Film)                                                    2963 (b), 2935 (s), 2858 (b), 1591 (b), 1499 
                                                                             (s), 1463 (b), 1414 (s), 1389 (s),  1246 (s),
                                                                             (s), 1089 (s), 1077 (s), 968 (b), 761 (s);
HRMS                                                               C15H20SN4 
                                                                             Calcld: 288.140
                                                                             Found: 288.141
Experimental Part                                                                                                                    75
5'-(2(R)-Methyl-hept-6-ene-1-sulfonyl)-1'-phenyl-1H-tetrazole (E) 
The sulfide 178 (29 mg, 0.11 mmol) was dissolved in EtOH (3.2 ml), cooled to 0 °C and a 
premixed bright yellow solution of (NH4)6Mo7O24 (5.12 mg, 0.022 mmol) in 35% aqueous 
solution of H2O2 (5.34 ml, 5.5 mmol) was added slowly over 5 minutes. The reaction was 
allowed to warm up to room temperature and stirred for 6 h. A mixture of EtOAc:H2O (1:1) 
(10 ml) was added and the layers were separated.  The aqueous layer  was extracted with 
EtOAc (3 x 15 ml) and the combined organic layer was washed with H2O (5 ml), brine (50 
ml),  and dried  over  MgSO4.  The  volatiles  were  removed  in  vacuo and the residue  was 
purified by flash chromatography with Pentane:Ether  (10:1) to afford sulfone  E (22 mg, 
0.069 mmol, 69%).   
General Data                                           C15H20N4O2S, M = 320.41 g/mol, yellowish oil; 
                                                                    Rf = 0.73 (Pentane: Ether, 1:1); 
                                                                    [α]20 = +17.1° (c = 1.0 CHCl3); UV (+); 
1H-NMR (400 MHz, CDCl3, δ ppm)       δ = 7.69-7.58 (m, H-2'', H-3'', H-4'', H-5'', H-6'',
                                                                   5H); 5.78 (ddt, 6.8 Hz, 10.6 Hz, 17.1 Hz, H-6, 1H)
                                                                   5.00-4.95 (m, H-7, 2H); 3.84-3.56 (dd, 12.6 Hz,
                                                                   7.5 Hz, H-1, 1H); 2.06 (d, 7.6 Hz, H-5, 2H); 1.99-
                                                                   1.93 (m, H-2, 1H); 1.58-1.38 (m, H-4, H-3, 4H); 
                                                                   1.25 (d, 7.0 Hz, H-1''', 3H);  
13C-NMR (100MHz, CDCl3, δ ppm)       δ = 154.07 (C-5'), 138.14 (C-6), 133.08 (C-1''),
                                                                   131.45 (C-2'', C-6''), 129.68 (C-4''), 125.05 (C-3'',  
                                                                   C-5''), 114.97 (C-7), 61.82 (C-1),  35.94 (C-3), 
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                                                                   33.45 (C-5), 28.1 (C-2), 25.58 (C-4), 19.70 (C-1'''); 
 MS (EI)                                                    320 (5%), 309 (6%), 279 (5%), 268 (15%), 241.1 
                                                                   (50%), 231.1 (16%), 227.1 (55%), 199.1 (55%), 
                                                                   173 (8%), 118.0 (100%), 91.1 (6%), 77.1 (25%),  
                                                                   55.0 (35%);
IR (Cap. Film)                                           3463 (b), 2931 (s), 2859 (b), 1737 (s), 1641 (s),
                                                                    1498 (s), 1462 (s), 1373 (s), 1243 (b), 1153 (s), 
                                                                    1047 (s), 1016 (s), 916 (s), 764 (s), 521 (s); 
HRMS                                                      C15H20N4O2S
                                                                   Calcld: 320.130
                                                                    Found: 320.131
2'-(2(R)-Methylhept-6-enylsulfanyl)-Benzothiazole (179)
A solution of the alcohol  77 (93 mg, 0.72 mmol), benzothiazole-thiol (84 mg, 1.32 mmol) 
and PPh3  (198.3 mg, 0.76 mmol) in THF (7.5 ml) was cooled to 0 °C and DIAD (264 mg, 
1.32 mmol, 0.25 ml) was added after 45 minutes[21]. The reaction was allowed to warm up to 
room temperature and stirred for 4 h. The volatiles were removed in vacuo and the residue 
was dissolved in Et2O (20 ml) and was kept for 4 h at -20 °C. The precipitated OPPh3 was 
removed by filtration and Et2O was removed in vacuo. The residue was purified by flash 
chromatography with Pentane:Ether (10:1) to afford sulfide 179 (180 mg, 0.65 mmol, 90%).
General Data:                                                   C15H19NS2, M = 277.10 g/mol, colourless oil; 
                                                                           Rf = 0.69 (100%EtOAc); Vanillin: blue;
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                                                                           [α]20 = - 49.5° (c = 1.03 CHCl3), UV (+);
1H-NMR (400 MHz, CDCl3, δ ppm)              δ = 7.78 (d, 7.6 Hz, H-5', 1H); 7.65 (d, 8.0 Hz
                                                                          H-8', 1H); 7.31-7.27 (m, H-6', H-7', 2H); 
                                                                          1.1 Hz, H-7', 1H); 5.75 (m, H-6, 1H); 5.02-
                                                                           4.85 (dd, 17.0 Hz, 10.0 Hz, H-7, 2H); 3.41-
                                                                           3.19 (dd, 12.0 Hz, 5.7 Hz, H-1, 2H); 2.06 (d, 
                                                                           6.9 Hz, H-5, 2H); 1.99-1.89 (m, H-2, 1H);
                                                                           1.62-1.25 (m, H-4, H-3, 4H); 0.99 (m, H-1''',
                                                                           3H);                                                  
13C-NMR (100MHz, CDCl3, δ ppm)              δ = 167.54 (C-2'), 153.27 (C-4'), 138.75 (C-6) 
                                                                           135.10 (C-9'), 125.91 (C-8'), 124.02 (C-5'),
                                                                           121.36 (C-6'), 120.82 (C-7'), 114.52 (C-7),
                                                                           40.56 (C-1), 35.46 (C-3),  33.75 (C-5), 33.08
                                                                           (C-2), 26.20 (C-4), 19.29 (C-1'''); 
MS (EI)                                                             277.1 (90%), 262.1 (20%), 223.1 (28%),
                                                                           167.1 (100%), 166.1 (50%), 77.1 (100%);
IR (Cap. Film)                                                   2928 (b), 1458 (s), 1428 (s), 996 (s), 755 (s), 
                                                                           726 (b); 
HRMS                                                             C15H19NS2
                                                                          Calcld: 277.100
                                                                          Found: 277.097
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2'-(2(R)-Methylhept-6-en-1-sulfonyl)-Benzothiazole (105)
The sulfide 179 (40 mg, 0.15 mmol) was dissolved in EtOH (4.4 ml), cooled to 0°C and a 
premixed bright yellow solution of (NH4)6Mo7O24 (7.15 mg, 0.03 mmol) in 35% aqueous 
solution of H2O2 (6.69 ml, 6.89 mmol) was added slowly over 5 minutes[21]. The reaction was 
allowed to warm up to room temperature and stirred for 6 h. A mixture of EtOAc:H2O (1:1) 
(10 ml) was added and the layers were separated.  The aqueous layer  was extracted with 
EtOAc (3 x 15 ml) and the combined organic layer was washed with H2O (5 ml), brine (50 
ml),  and dried  over  MgSO4.  The  solvents  were  removed  in  vacuo and  the residue  was 
purified with flash chromatography with Pentane:Ether (10:1) to afford sulfone 105 (29 mg, 
0.094 mmol, 63%).  
General Data:                                                 C15H19NO2S2, M = 309.45 g/mol; yellowish oil; 
                                                                       Rf = 0.61 (Pentane: Ether, 1:1); Vanillin: blue; 
                                                                       [α]20 = -7.2° (c = 1.03 CHCl3);  UV (+);
1H-NMR (400 MHz, CDCl3, δ ppm)           δ = 8.21 (d, 7.9 Hz, 1H, H-5'); 8.02  (dd, 8.1 Hz
                                                                       1.5 Hz, H-8', 1H); 7.62-7.57 (m, H-6', H-7', 2H);
                                                                       5.73 (ddt, 10.0 Hz, 17.0 Hz, 6.7 Hz, H-6, 1H);
                                                                       4.93-4.87 (m, H-7, 2H); 3.56-3.35 (dd, 4.0 Hz
                                                                       8 Hz, H-1, 1H); 2.32-2.24 (m, H-2, 1H);2.00- 
                                                                       1.95 (m, H-5, 2H); 1.6-1.23 (m, H-3, H-4, 4H);
                                                                       1.14 (m, H-1''', 3H);
13C-NMR (100MHz, CDCl3, δ ppm)           δ = 166.61 (C-2'), 152.57 (C-4'), 138.13 (C-6), 
                                                                       136.61 (C-9'), 127.91 (C-8'), 127.55 (C-5'),
                                                                       125.28 (C-6'), 122.27 (C-7'), 114.70 (C-7),
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                                                                       60.62 (C-1), 35.90 (C-3),  33.36 (C-5), 28.33
                                                                       (C-2), 25.47 (C-4), 19.73 (C-1'''); 
MS (EI)                                                            310.1 (43%), 295.1 (95%), 268.1 (100%), 188.0
                                                                       (90%), 135.0 (100%), 55.0 (55%);
IR (Cap. Film)                                                  3452 (s), 3069 (s), 2931 (s), 1738 (s), 1640 (s), 
                                                                       1473 (s), 1325 (s), 1148 (s), 763 (s), 631 (s);
HRMS                                                          C15H19NO2S2
                                                                                                                          Calcld: 309.090
                                                                       Found: 309.085
2-Triisopropylsilanyloxy-ethanol (204) 
Ethylene  glycol  79 (1.00 g,  15.6 mmol)  was added dropwise to  NaH (624 mg,  60% in 
mineral oil, 15.6 mmol) suspended in THF (30 ml). After 1 h vigorous stirring, TIPSCl (3.34 
ml, 46.8 mmol) was added in a single portion and the solution was further stirred for 3.5 h at 
room temperature[25]. The reaction was acidified with saturated aqueous NH4Cl (250 ml) and 
extracted with EtOAc (3 x 75 ml). The organic layer was successively washed with 10% 
aqueous  NaHCO3  (100  ml),  brine  (100  ml)  and  dried  over  Na2SO4.  The  volatiles  were 
concentrated  in  vacuo  and  the  residue  was  purified  by  flash  chromatography  with 
Pentane:Ether (2:1) to afford TIPS-protected alcohol 204 (2.80 g, 12.8 mmol, 80%).
General Data:                                     C11H26O2Si, M = 218.41 g/mol, colorless oil; 
                                                                      Rf = 0.58 (100% EtOAc); UV (-); Vanillin: blue; 
1H-NMR (400 MHz, CDCl3, δ ppm)          δ = 3.70 (m, H-1, 2H); 3.57 (m, H-2, 2H); 2.72 
                                                                      (s, OH, 1H); 1.12,0.98 (m, OTIPS, 21H); 
HO
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13C-NMR (100MHz, CDCl3, δ ppm)          δ = 64.24 (C-1), 63.48 (C-2), 17.68  (OTIPS), 
                                                                       11.73 (OTIPS);
MS (EI)                                                         218.1 (11%), 157.3 (100%), 115.2 (45%), 103.2
                                                                      (20%), 87.2 (20%), 75.1 (19%), 59.1 (16%);
IR (Cap. film)                                               3351 (b), 2944 (s), 2893 (s), 2868 (s), 1464 (s), 
                                                                      1384 (s), 1368 (s), 1249 (s), 1120 (s), 1060 (s),
                                                                      937 (s), 681 (s);
HRMS                                                          C11H26O2Si
                                                                      Calcld: 218.170
                                                                      Found: 218.172
2-(tert-Butyldimethylsilanyloxy)-ethanol (141)
Ethylene glycol 79 (3.00 g, 46.8 mmol) was added dropwise to NaH (1.87 g, 60% in mineral 
oil, 46.8 mmol) suspended in THF (90 ml). After 1 h vigorous stirring, TBSCl (7.02 g, 46.8 
mmol) was added in a single portion and the solution was further stirred for 3.5 h at room 
temperature.  The  reaction  was  acidified  with  saturated  aqueous  NH4Cl  (250  ml)  and 
extracted with EtOAc (5 x 150 ml). The organic layer was successively washed with 10% 
aqueous  NaHCO3  (300  ml),  brine  (300  ml)  and  dried  over  Na2SO4.  The  volatiles  were 
concentrated in vacuo and was purified by flash chromatography with Pentane:Ether (2:1) to 
afford TBS-protected alcohol 141 (7.0 g, 39.7 mmol, 85%).
General Data:                                          C8H20O2Si, M = 176.33 g/mol, colorless oil;  
                                                                        Rf = 0.56 (100% EtOAc); 
                                                                             UV (-); Vanillin: dark blue; 
1H-NMR (400 MHz, CDCl3, δ ppm)               δ = 3.66 (m, H-1, 2H); 3.58 (m, H-2, 2H);
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                                                                            2.57 (br, OH, 1H); 0.85 (s, OTBS, 9H); 0.03 
                                                                             (s, OTBS, 6H);
13C-NMR (100MHz, CDCl3, δ ppm)               δ = 64.12 (C-1), 63.52 (C-2), 25.79 (OTBS),
                                                                             18.22 (OTBS), -5.47 (OTBS);
MS (EI)                                                         176.1 (5%), 161.1 (35%), 147.1 (100%),  
                                                                             119.0 (8%), 89.0 (20%), 75.0 (19%), 59.0
                                                                             (16%);     
IR (Cap. film)                                                 3402 (b), 2955 (s), 2931 (s), 2886 (s), 1473 
                                                                       (s), 1464 (s), 1390 (s), 1060 (s), 664 (s);
HRMS                                                           C8H20O2Si
                                                                       Calcld: 176.120
                                                                             Found: 176.123    
2-Triisopropylsilanyloxy-acetaldehyde (137)
Oxalyl  chloride (2.16 ml,  24.8 mmol) was added dropwise to -78 °C cooled solution of 
DMSO (3.52 ml, 49.5 mmol) and Et3N (8.63 ml, 61.9 mmol) dissolved in CH2Cl2 (115 ml). 
After stirring for 5 minutes, 204 (2.73 g, 12.4 mmol) was added via cannula as a solution in 
CH2Cl2 (10 ml). After 30 minutes, the reaction was allowed to warm to 0 °C over the course 
of 1 h and CH2Cl2  (75 ml) was added to the reaction mixture[25]. The reaction mixture was 
successively washed with saturated aqueous NH4Cl (100 ml), 10% aqueous NaHCO3  (100 
ml), brine (100 ml) and dried over Na2SO4. The volatiles were concentrated in vacuo and the 
oily residue was purified by flash chromatography with  Pentane:Ether (2:1)  to afford the 
aldehyde 137 (2.31 g, 10.6 mmol, 86%).
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General Data:                                                C11H24O2Si, M = 216.39 g/mol, colorless oil; 
                                                                           Rf = 0.65 (100% EtOAc); 
                                                                           UV (-); Vanillin: dark brown; 
1H-NMR (400 MHz, CDCl3, δ ppm)              δ = 9.74 (m, H-1, 1H); 4.26 (m, H-2, 2H); 
                                                                           1.25,1.08 (m, OTIPS, 21H);
13C-NMR (100MHz, CDCl3, δ ppm)              δ = 203.02 (C-1), 69.70 (C-2), 17.81 (OTIPS),
                                                                           11.88 (OTIPS); 
MS (EI)                                                         217.3 (5%), 175.3 (38%), 131.2 (85.1%), 
                                                                           103.1 (100%), 75.1 (35%), 65.1 (20%);
IR (Cap. film)                                                    3651 (s), 3314 (s), 2944 (s), 2893 (s), 2867(s)
                                                                           1464 (s), 1384 (s), 1368 (s), 883 (s) 788 (s);
HRMS                                                              C11H24O2Si
                                                                           Calcld: 216.150
                                                                           Found: 216.161 
2-(tert-Butyldimethylsilanyloxy)-acetaldehyde (142)
Oxalyl  chloride  (0.42 ml  4.96 mmol)  was added dropwise to  -78 °C cooled solution of 
DMSO (0.65 ml, 9.9 mmol) and  Et3N (1.6 ml, 12.39 mmol) dissolved in  CH2Cl2 (27 ml). 
After stirring it for 5 minutes compound 141 (0.5 g, 2.48 mmol) was added via cannula as a 
solution in CH2Cl2 (5 ml). After 30 minutes, the reaction was allowed to warm to 0 °C over 
the course of 1h. Then, CH2Cl2 (75 ml) was added and the reaction mixture was successively 
washed with saturated aqueous NH4Cl (100 ml), 10% aqueous NaHCO3 (100 ml), brine (100 
ml) and dried over Na2SO4. The volatiles were concentrated  in vacuo and the oily residue 
was purified by flash chromatography with Pentane:Ether (2:1)  to afford the aldehyde  142 
(0.35 g, 2.0 mmol, 81%).
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General Data:                                                 C8H18O2Si, M = 174.31 g/mol, colorless oil;   
                                                                           Rf = 0.68 (100% EtOAc);
                                                                           UV (-); Vanillin: brown; 
1H-NMR (400 MHz, CDCl3, δ ppm)               δ = 9.65 (m, H-1, 1H); 4.17 (m, H-2, 2H); 
                                                                      0.89 (s, OTBS, 9H); 0.06 (s, OTBS, 6H); 
13C-NMR (100MHz, CDCl3, δ ppm)               δ = 202.03 (C-1), 69.51 (C-2), 25.77 (OTBS), 
                                                                           18.32 (OTBS), -5.54 (OTBS); 
MS (EI)                                                            175.1 (5%), 159.1 (12%), 133.0 (28%),
                                                                           117.0 (69%), 75.1 (100%);
IR (Cap. film)                                                    3469 (b), 2955 (s), 2887 (s), 1764 (s), 1739  
                                                                           (s), 1464 (s), 1389 (s), 1256 (s), 1150 (s), 
                                                                           837 (s), 664 (s);
HRMS                                                             C8H18O2Si
                                                                           Calcld: 174.110
                                                                           Found: 174.120
Acetic acid 2-hydroxy-ethyl ester (205)
Trimethyl-orthoacetate  (2.98  ml,  23.4  mmol)  was  added  to  a  room temperature  stirring 
solution of ethylene glycol 79 (1.00 g, 15.6 mmol), PPTS (148 mg, 0.78 mmol) and CH2Cl2 
(150 ml)[25]. After stirring it for 6 minutes, distilled water (422 µl) was added in a single 
portion and the mixture  was stirred further  for additional  6 minutes.  The volatiles  were 
removed in vacuo and the residue was purified by flash chromatography with Hexane:Ether 
(9:1) to afford alcohol 205 (1.50 g, 14.4 mmol, 93%).
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General Data:                                                        C4H8O3, M = 104.10 g/mol, colorless oil; 
                                                                                  Rf = 0.45 (100% EtOAc) 
                                                                                  Vanillin: yellow; UV(-); 
1H-NMR (400 MHz, CDCl3, δ ppm)                      δ = 3.89 (m, H-1, 2H);  3.78 (s, OH, 1H); 
                                                                                  3.51 (m, H-2, 2H); 1.81 (s, OAc-CH3, 
                                                                                  3H); 
13C-NMR (100MHz, CDCl3, δ ppm)                      δ = 171.0 (COCH3), 65.3 (C-1), 59.7 
                                                                                  (C-2), 20.1 (COCH3);       
MS (EI)                                                                   104.1 (19%), 91.0 (76%), 87.0  (100%),
                                                                                  77.0 (63%), 57 (25%);
IR (Cap.film)                                                            3439 (s), 2955 (s), 1738 (s), 1442 (s), 
                                                                                  1380 (s), 1247 (b), 1083 (s), 1047 (s),
                                                                                  885 (s), 607 (s);
HRMS                                                                    C4H8O3
                                                                                  Calcld:104.050
                                                                                  Found:104.048
Acetic acid 4-acetoxy-but-2-enyl ester (145)
To a solution of cis-2-butene-1,4-diol 144 (1.0 g, 11.4 mmol) in pyridine (5 ml) was added 
Ac2O (6.4 ml, 34.2 mmol). The mixture was stirred at room temperature for 1 h and was 
then extracted with EtOAc (3 x 50 ml). The organic phase was successively washed with 1N 
HCl (5 x 25 ml), brine (25 ml) and was dried over Na2SO4. Volatiles were concentrated in 
vacuo and the residue was purified by flash chromatography with Pentane:EtOAc (20:1) to 
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afford the diacylated alkene 145 (1.68 g, 9.8 mmol, 86%).
General Data:                                                       C8H12O4, M = 172.18 g/mol, colorless oil; 
                                                                                 Rf = 0.65 (100% EtOAc);
                                                                                 Vanillin: Violet; UV (-); 
1H-NMR (400 MHz, CDCl3, δ ppm)                     δ = 5.5 (m, H-2, H-3, 2H); 4.5 (m, H-1, 
                                                                                 H-4, 4H); 1.84 (s, COCH3, 6H);
13C-NMR (100MHz, CDCl3, δ ppm)                    δ = 170.16 (COCH3), 127.55 (C-2, C-3), 
                                                                                 59.37 (C-1, C-4), 20.16 (COCH3); 
MS (EI)                                                                  172 (85%), 142 (46%), 87 (100%), 70
                                                                                 (100%), 43 (100%);
IR (Cap. film)                                                          3462 (s), 3036 (s), 2945 (s), 2464 (s), 
                                                                                 2062 (s), 1742 (s), 1439 (s), 1374 (s),  
                                                                                 1227 (b), 1033 (s), 967 (s), 890 (s), 840 
                                                                                 (s), 731 (s), 635 (s), 607 (s);
HRMS                                                                   C8H12O4
                                                                                Calcld: 172.070
                                                                                Found: 172.074
Acetic acid 2-oxo-ethyl ester (146)
The protected alkene 145 (1.00 g, 19.2 mmol) was dissolved in CH2Cl2  (15 ml), CH3OH (5 
ml) and cooled to -78 °C. Ozone was run into the reaction and the color turned to blue in
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just  10 minutes.  The reaction  mixture  was treated  with PPh3  (2.5 g,  8.4 mmol)  and the 
volatiles were concentrated in vacuo. The residue was purified by flash chromatography with 
Pentane:Ether (1:1) to afford the aldehyde 146 (0.98 g, 9.6 mmol, 51%).
General Data:                                                         C4H6O3, M = 102.09 g/mol, colorless oil; 
                                                                                   Rf = 0.53 (100% EtOAc);
                                                                                   Vanillin: Dark brown, UV (-); 
1H-NMR (400 MHz, CDCl3, δ ppm)                       δ = 9.53 (m, H-2, 1H); 4.66 (m, H-1, 
                                                                                   2H); 2.18 (s, COCH3, 3H); 
13C-NMR (100MHz, CDCl3, δ ppm)                       δ = 195.6 (C-2), 170.6 (COCH3), 68.9 
                                                                                   (C-1), 20.7 (COCH3);   
IR (Cap. film)                                                            2953 (s), 1739 (s), 1725 (s), 1677 (s), 
                                                                                   1436 (s), 1377 (s), 1234 (s), 1042 (s); 
4-Triisopropylsilanyloxy-butan-1-ol (75)
To a solution of NaH (1.9 g, 60% in mineral oil, 46.8 mmol) suspended in THF (90 ml) was 
added dropwise 1,4-butanediol  78 (4.2 g, 46.8 mmol). After 1 h vigorous stirring, TIPSCl 
(10.02 ml, 140.4 mmol) was added in a single portion and the solution was stirred further for 
3.5 h at room temperature. The reaction was acidified with saturated aqueous NH4Cl (250 
ml) and extracted with EtOAc (3 x 75 ml). The organic layer was successively washed with 
10% aqueous NaHCO3  (100 ml), brine (100 ml) and dried over Na2SO4. The volatiles were 
concentrated  in  vacuo  and  the  residue  was  purified  by  flash  chromatography  with 
Pentane:Ether (2:1) to afford TIPS-protected alcohol 75 (9.5 g, 38.4 mmol, 82%).
General Data:                                         C13H30O2Si, M = 246. 46 g/mol, colourless liquid; 
                                                                   Rf  = 0.74 (100% EtOAc); UV (+); Vanillin (-);
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1H-NMR (400 MHz, CDCl3, δ ppm)      δ = 3.70 (m, H-1, 2H); 3.60 (m, H-4, 2H); 3.0 (s,
                                                                   OH, 1H); 1.60 (m, H-2, H-3, 4H); 1.63,0.98 (m,
                                                                   OTIPS, 21H); 
13C-NMR (100MHz, CDCl3, δ ppm)       δ = 63.49 (C-1), 62.56 (C-4), 30.52 (C-3), 29.91 
                                                                   (C-2), 17.87 (OTIPS), 11.87 (OTIPS); 
MS (EI)                                                  246.2 (25%), 203.2 (46%), 143.1 (100%), 131.1
                                                                   (78%), 119.1 (100%), 103.1 (100%), 75.0 (35%);
IR (Cap. Film)                                        3339 (b), 2943 (m), 2867 (s), 2727 (b), 1464 (s),
                                                                   1384 (s), 1367 (s), 1248 (s), 951 (s), 681 (s); 
HRMS                                                  C13H30O2Si
                                                               Calcld: 246.200
                                                               Found: 246.201
1'-Phenyl-5'-(4-Triisopropylsilanyloxy-butane-1-sulfonyl)-1H-tetrazole (F) 
A solution of the alcohol 75 (2 g, 8.11 mmol), PT-SH (1.52 g, 8.51 mmol) and PPh3 (2.24 g, 
8.51 mmol, 1.05 equiv.) in THF (81 ml) was cooled to 0 °C and DIAD (1.93 ml, 9.6 mmol,  
1.2 equiv) was added after 45 minutes of stirring. The reaction mixture was allowed to warm 
to room temperature and stirred for 4 h. Volatiles were removed under reduced pressure and 
the crude reaction mixture was dissolved in Et2O (72 ml) and kept for 4 h at -20°C. The 
precipitated OPPh3 was removed by filtration and volatiles were removed under reduced 
pressure. The residue was dissolved in EtOH (40 ml) and cooled to 0 °C and a premixed 
bright yellow solution of (NH4)6Mo7O24 (372.5 mg, 1.62 mmol) in 35% aqueous solution of
NN
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H2O2 (78.6 ml 80.0 mmol)  was added slowly over 5 minutes.  The reaction mixture was 
allowed to warm up to room temperature and stirred for 6 h. A mixture of EtOAc:H2O (100 
ml) was added and the layers were separated. The aqueous layer was extracted with EtOAc 
(3x150 ml) and the combined organic phase was washed with H2O (50 ml), brine (50 ml), 
dried over MgSO4. The solvents were evaporated in vacuo and crude product was purified 
by flash chromatography with EtOAc:MeOH (100:0→25:1)  to afford sulfone  fragment F 
( 2.5 g, 5.7 mmol, 70 %).
General Data:                                          C20H34N4O3SSi, M = 438.66 g/mol, white solid; 
                                                                    Rf  = 0.79 (Pentane: Ether, 1:1); 
                                                                    UV (+); Vanillin (-);
1H-NMR (400 MHz, CDCl3, δ ppm)       δ = 7.58-7.43 (m, aromatic CH, 5H), 3.80 (m, H-4 
                                                                    2H); 3.73 (m, H-1, 2H); 2.04 (m, H-2, 2H); 1.70
                                                                    (m, H-3, 2H); 1.21,1.02 (m, OTIPS, 21H);
13C-NMR (100MHz, CDCl3, δ ppm)        δ = 153.32 (C-5'), 132.95, 131.23, 129.51, 124.97
                                                                    (aromatic CH), 62.26 (C-4), 55.80 (C-1), 30.93 
                                                                       (C-3),  18.76  (C-2), 17.87 (OTIPS), 11.87
                                                                       (OTIPS);  
IR (Cap. Film)                                           3468 (b), 2893 (s), 2867 (b), 1711 (s), 1463 (s),
                                                                    1366 (s), 1344 (s), 1256 (s), 1151 (b), 1108 (s), 
                                                                    1073 (s), 1014 (s), 918 (s), 761 (s), 668 (s); 
(4-Iodo-butoxy)-triisopropyl-silane (187)
To a  0 °C cooled  solution  of  PPh3  (3.07 g,  11.7 mmol)  in  CH2Cl2   (50 ml)  was added 
imidazole (810 mg, 11.7 mmol) and I2 (2.96 g, 11.7 mmol). The reaction was stirred for 10
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minutes at 0°C and alcohol  75 (1.91 g, 7.8 mmol) was added to the reaction mixture. The 
reaction was stirred for another 30 minutes with the same temperature and  volatiles were 
concentrated  in  vacuo.  The  residue  was  purified  by  flash  chromatography  with 
Pentane:Ether (10:1)  to afford 187 (2.5 g, 7.01 mmol, 89.9 %).
General Data:                                       C13H29IOSi, M = 356.36 g/mol, colourless liquid; 
                                                                  Rf  = 0.69 (Pentane: Ether, 1:1); 
                                                                  UV (+); Vanillin (-);
1H-NMR (400 MHz, CDCl3, δ ppm)     δ = 3.71 (m, H-1, 2H); 3.20 (m, H-4, 2H); 1.93 (m, 
                                                                  H-2, 2H); 1.62 (m, H-3, 2H); 1.25,1.04 (m, OTIPS,
                                                                  21H); 
13C-NMR (100MHz, CDCl3, δ ppm)     δ = 62.07 (C-1), 33.61 (C-2), 30.19 (C-3), 17.95
                                                                  (OTIPS), 11.88 (OTIPS), 6.52 (C-4); 
MS (EI)                                                 356.1 (5%), 313.0 (14%), 241.0 (40%), 228.9  
                                                                  (100%), 212.9 (28%), 115.1 (18%), 75 (11%);
IR (Cap. Film)                                       2942 (m), 2866 (s), 2726 (m), 1463 (s), 1383 (s),
                                                                     1367 (s), 1292 (s), 957 (s), 681 (s); 
HRMS                                                 C13H29IO2Si                 
                                                                 Calcld: 356.100
                                                                  Found: 356.105 
Triphenyl-(4-triisopropylsilanyloxy-butyl)-phosphonium iodide (188)
Iodide 187 (1 g, 2.8 mmol) and PPh3 (810 mg, 11.7 mmol) was dissolved in  CH3CN (33.5 
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ml) and the reaction was stirred at room temperature for 24 h. Solvents were removed in 
vacuo and the residue was cleaned by flash chromatography with Pentane:Ether (100:1) to 
afford 188 (1.2 g, 1.94 mmol, 69%). 
General Data:                                          C31H44IOPSi, M = 618.14 g/mol, white solid; 
                                                                    Rf  = 0.72 (Pentane: Ether, 1:1);
                                                                    UV (+); Vanillin (-);
  1H-NMR (400 MHz, CDCl3, δ ppm)       δ = 7.41-7.28 (m, Ph, 15H); 3.85 (m, H-1, 2H); 
                                                                      3.27 (m, H-4, 2H); 2.03 (m, H-2, 2H); 1.71 (m
                                                                      H-3, 2H); 1.37,1.16 (m, OTIPS, 21H); 
13C-NMR (100MHz, CDCl3, δ ppm)       δ = 136.86-128.10 (Ph, 18C);  61.85 (C-1), 33.32  
                                                                    (C-2), 29.89 (C-3), 17.75 (OTIPS), 11.61 (OTIPS)
                                                                    6.92 (C-4); 
MS (EI)                                                      618.2 (5%), 491.3 (14%), 241.0 (40%), 228.9  
                                                                    (100%), 212.9 (28%), 115.1 (18%), 75 (11%);
IR (Cap. Film)                                         3834 (m), 3339 (s), 2891 (m), 2922 (s), 2863 (s),
                                                                       2220 (s), 1586 (s), 1462 (s), 1435 (s), 1110 (s),
                                                                    997 (s), 881 (s), 741 (s), 500 (s), 690 (s);
HRMS                                                   C31H44IOPSi                         
                                                                Exact Mass: 618.190                              
                                                          Found: 618.205
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(Z)-Acetic acid 2-trimethylsilanyloxy-vinyl ester (139)                      
To a room temperature solution of TMSCl (3.95 ml, 24.4 mmol), Et3N (5.1 ml, 36.5 mmol), 
and CH3CN (11 ml) was added aldehyde 146 (1.35 g, 6.1 mmol) dissolved in CH3CN (1.5 
ml). In less than 5 minutes, the solution becomes a hot white suspension that turned into a 
rust colored suspension with in 15 minutes. The reaction was stirred for 2 h and volatiles 
were removed in vacuum and the residue was extracted with Et2O (3 x 50 ml). The volatiles 
were concentrated in vacuo to afford TMS-protected alkene  139 (0.69 g, 4.0 mmol, 66%, 
E:Z, 1:7.5).
General Data:                                                    C7H14O3Si, M = 174.27 g/mol, colorless oil; 
                                                                               Rf = 0.67 (100% EtOAc) 
                                                                               UV (-); Vanillin: brown;
1H-NMR (400 MHz, CDCl3, δ ppm)                 δ = 6.55 (d, 3.5 Hz, H-1, 1H); 5.59 (d, 3.3  
                                                                               Hz, H-2, 1H); 1.94 (s, COCH3, 3H); 0.03
                                                                               (s, OTMS, 9H); 
13C-NMR (100MHz, CDCl3, δ ppm)                 δ = 169.8 (COCH3), 127.3 (C-1), 120.4 
                                                                               (C-2), 20.9 (COCH3), -0.24 (OTMS); 
(2R,3R)-2,4-Bis-(tert-butyl-dimethyl-silanyloxy)-3-hydroxy-butanal (143)
D-proline (38.2 mg, 0.33 mmol) was added to a room temperature mixture of aldehyde 142 
(1.45 g, 8.33 mmol) dissolved in DMSO (13.3 ml). After 28 h, the solution was diluted with 
EtOAc (150 ml) and successively washed with water (100 ml), brine (100 ml), and dried 
over Na2SO4. The volatiles were concentrated in vacuo and the residue was purified by flash 
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chromatography with Pentane:THF (49:1) to afford yellowish oily liquid as diasteromers 
143 (2.18 g, 6.3 mmol, 76%, syn:anti, 1:3.4).
General Data:                                          C16H36O4Si2, M = 348.63 g/mol, yellowish oil;
                                                                         Rf = 0.55 (100% EtOAc); 
                                                                         UV(-); Vanillin: brown;
1H NMR (400 MHz, CDCl3, δ ppm)             δ = 9.64 (d, 1.65 Hz, H-1, 1H); 4.10 (m, H-2, 
                                                                         1H); 3.90 (m, H-3, 1H); 3.70 (m, H-4, 2H);
                                                                         2.44 (s, OH, 1H); 0.92 (s, OTBS, 9H); 0.89 (s,
                                                                         OTBS, 9H), 0.08,0.06 (s, OTBS, 12H);
13C NMR (100MHz, CDCl3, δ ppm)             δ = 201.85 (C-1), 78.31 (C-2), 72.91 (C-3), 
                                                                         62.30 (C-4), 25.81,25.70 (OSiC(CH3)3), 18.2
                                                                         (OSiC(CH3)3), -4.58,-4.66 (OSi(CH3)2);
MS (EI)                                                               349.1 (43%), 319.2 (95%), 301.1 (25%), 273.1
                                                                         (35%), 231.1 (100%), 117.1 (100%), 73.0 (72);
IR (Cap. Film)                                            3437 (b), 2930 (s), 2886 (s), 2859 (s),  2251 
                                                                         1740 (s), 1701 (s), 1390 (s), 1255 (b), 837 (s)
                                                                         779 (s), 671 (s);
HRMS                                                   C16H36O4Si2
                                                              Calcld: 348.220
                                                                        Found: 348.216
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3-(tert-Butyl-dimethyl-silanyloxy)-2-(tert-butyl-dimethylsilanyloxymethyl) 
-3,4-dihydro-2H-pyran-4-ol (149)      
The aldol 143 (100 mg, 0.23 mmol) was added as a solution in Et2O (2.3 ml) to a mixture of 
MgBr2.Et2O (129 mg, 0.65 mmol) in Et2O (2.3 ml) which was cooled to –20 °C. After 30 
minutes at -20 °C, 139 (85 μl, 0.92 mmol) was added[25]. The suspension was stirred at -20 
°C for 2 h, and then allowed to warm to +4 °C over the course of 4 h. After stirring for an 
additional 24 h at +4 °C, the reaction was acidified by the addition of 100 ml saturated  
aqueous NH4Cl and extracted with EtOAc (2 x 50 ml). The organic layer was washed with 
brine (100 ml), dried over Na2SO4  and concentrated in vacuo. The residue was poured to a 
solution of THF:TFA:H2O (5 ml, (7:2:1)) at 0 °C and stirred for 30 minutes before being 
basified with 10% NaHCO3 (50 ml), extracted with EtOAc (100 ml), dried over Na2SO4. The 
volatiles  were  concentrated  in  vacuo  to  afford  suspension 148 (85  mg,  0.17  mmol). 
Compound  148 was dissolved in  Ac2O (1.80  mg,  0.07  mmol)  and  HBr  (100 mg,  33% 
solution in AcOH) was added in small portion. After 1 h the solution was treated with HBr 
(740 mg, 33% solution in AcOH). After 24 h stirring the reaction mixture was treated with 
NaOAc  (300  mg)  and  the  resulting  solution  was  immediately  added  in  portions  to  an 
aqueous suspension of CuSO4.5H2O (13 mg), Zinc (1.02 g) in H2O (5 ml) and AcOH (7.5 
ml)  containing  NaOAc.3H2O  (1.25  g).  The  mixture  was  vigorously  stirred  at  room 
temperature for 2 h and inorganic solid was filtered off and successively washed with EtOAc 
(3.5 ml) and H2O (5 ml). The organic layer was washed with saturated aqueous NaHCO3 (5 
ml), brine (2.5 ml) and dried over Na2SO4. The solvents were evaporated in vacuo to afford 
149 (43 mg, 0.11 mmol, 60%).
General Data                                          C18H38O4Si2 M = 374.66 g/mol, colorless syrup; 
                                                                       Rf = 0.65 (100 % EtOAc); 
                                                                       UV(-); Vanillin: dark brown;
1H NMR (400 MHz, CDCl3, δ ppm)          δ = 6.27 (d, 7.4 Hz, H-6, 1H), 4.62 (d, 8.5 Hz, 
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                                                                       H-5, 1H), 4.22-3.75 (m, H-2, H-3, H-4, H-1', 
                                                                       5H), 2.64 (s, OH, 1H), 0.90,0.86 (s, OSiC(CH3)3
                                                                       18H); 0.11,0.08 (s, OSi(CH3)2, 12H); 
13C NMR (100MHz, CDCl3, δ ppm)          δ = 143.29 (C-6), 103.43 (C-5), 77.96 (C-2),
                                                                       70.93 (C-3), 69.86 (C-4), 63.11 (C-1'), 25.92, 
                                                                       25.82 (OSiC(CH3)3); 18.39, 18.12 (OSiC(CH3)3)
                                                                       -3.60 (OSi(CH3)2); -4.47 (OSiCH3); -4.50
                                                                       (OSiCH3);
IR (Cap. Film)                                          3468 (b), 3070 (s), 2986 (s), 2930 (s), 2858 (s)  
                                                                       1651 (s), 1463 (s), 1390 (s), 1257 (s), 837 (s)
                                                                       779 (s), 669 (s); 
(2S,3R,4S) Acetic acid 3,4-diacetoxy-3,4-dihydro-2H-pyran-2-yl-methyl 
ester (150)
To a magnetically stirred suspension of L-glucose 98 (1.0 g, 5.37 mmol) in Ac2O (3.61 g, 
0.7  mmol),  was  added  HBr  (1.0  g,  33%  solution  in  AcOH)  in  small  portion  while 
maintaining the reaction to room temperature with the help of water bath[21]. After 1 h the 
clear solution was treated with the remaining HBr (7.4 g, 33% solution in AcOH) and the 
resulting solution was stirred overnight at room temperature. Anhydrous NaOAc (3.0 g) was 
added to neutralize the excess HBr and the resulting solution was immediately added in 
portions to an aqueous suspension of CuSO4.5H2O (260 mg) and zinc (10.2 g) in water (100 
ml) and acetic acid (150 ml) containing NaOAc.3H2O (12.5 g). The mixture was vigorously 
stirred at room temperature for 2 h. The inorganic solid was filtered off and washed with 
EtOAc (70 ml) and water (100 ml). The organic layer was washed with saturated NaHCO3 
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(100 ml) and brine (50 ml) and dried over Na2SO4. The solvents were evaporated in vacuo to 
afford tri-O-acetyl L-glucal 150 (1.4 g, 5.15 mmol, 96%). 
General Data                                              C12H16O7, M = 272.25 g/mol, colorless syrup; 
                                                                             Rf = 0.54 (CH2Cl2/EtOAc, 1:1); 
                                                                             UV(-); Vanillin: brown; 
1H NMR (400 MHz, CDCl3, δ ppm)               δ = 6.38 (d, 8.3 Hz, H-6, 1H), 5.25-5.10 (m, 
                                                                             H-5, H-4, 2H), 4.3 (m, H-3, 1H), 4.75 (m, 
                                                                             H-2, 1H), 4.20-4.00 (m, H-1', 2H), 2.00 (s,  
                                                                             COCH3, 9H); 
13C NMR (100MHz, CDCl3, δ ppm)               δ = 170.31 (COCH3), 170.14 (COCH3), 
                                                                            169.32 (COCH3), 145.40 (C-6), 98.75 (C-5), 
                                                                            73.68 (C-3), 67.19 (C-2), 66.91 (C-4), 61.10 
                                                                             (C-1'), 20.70,20.51,20.08 (COCH3);
MS (EI)                                                        272.1 (5%), 202.1 (5%), 152.1 (25%), 139.1 
                                                                             (70%), 110 (64%), 97 (100%);
 IR (Cap. Film)                                                   3456 (b), 2960 (s), 1748 (m), 1649 (s), 1372 
                                                                             (s), 1228 (s), 1045 (s); 
HRMS                                                 C12H16O7  
                                                                             Calcld: 272.090
                                                                             Found: 272.089
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(2S,3R,4S)-2-Hydroxymethyl-3,4-dihydro-2H-pyran-3,4-diol (99)
A mixture of the solvents CH3OH/H2O/Et3N (10 ml,  4:5:1) was added to tri-O-acetyl  L-
glucal 150 (0.7 g, 2.75 mmol). The reaction was stirred for 4 h and solvents were evaporated 
in vacuo to afford L-glucal 99 as syrup (0.37 g, 2.53 mmol, 91%).
General Data:                                              C6H10O4, M = 146.14g/mol, colourless syrup; 
                                                                            Rf = 0.22 (CH2Cl2/ EtOAc, 1:1); 
                                                                            Vanillin: brown; UV(-); 
1H NMR (400 MHz, CDCl3, δ ppm)              δ = 6.33 (d, 6.0 Hz, H-6, 1H); 4.75 (m, H-5,  
                                                                            1H); 4.30 (m, H-2, 1H); 3.98-3.77 (m, H-3, 
                                                                            H-4, H-1', 4H), 2.0 (s, OH, 3H); 
13C NMR (100MHz, CDCl3, δ ppm)               δ = 143.99 (C-6), 103.16 (C-5), 78.06 (C-3), 
                                                                            70.41 (C-2), 69.84 (C-4), 61.64 (C-1'); 
MS (EI)                                                       146.2 (5%), 101.2 (40%), 86.2 (100%), 73.1
                                                                            (12%), 58.1 (48%);
HRMS                                                C6H10O4
                                                                            Calcld: 146.061
                                                                            Found: 146.050
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(2S,3R,6S)-3-Acetoxy-2-acethoxymethyl-6-allyl-3,6-dihydro-2H-pyran 
(154)
To a solution of tri-O-acetyl L-glucal  150 (2.72 g, 10 mmol) in dry CH3CN (40 ml) was 
added ATMS (1.91 ml, 12 mmol) at 0 °C followed by TMSOTf (1.93 ml, 10 mmol). After  
stirring it for 30 minutes, the reaction was quenched with saturated aqueous NaHCO3 and 
the phases were separated. The organic phase was washed with brine and the aqueous layer 
was extracted with EtOAc (4 x 50 ml). The combined organic layer was dried over MgSO4 
and volatiles were concentrated in vacuo to afford clear brownish syrup  154 (2.30 g, 9.06 
mmol, 91%). It was used for the next step directly.
General Data:                                                C13H18O5, M = 254.28 g/mol; brownish syrup; 
                                                                           Rf = 0.58 (Pentane: Ether, 1:1); Vanillin: blue; 
                                                                           [α]20 = -61.3° (c = 1.8 CHCl3); UV (-); 
1H NMR (400 MHz, CDCl3, δ ppm)             δ = 5.93 (ddd, 10.3 Hz, 2.4 Hz, 1.6 Hz, H-4 
                                                                          1H); 5.84 (dddd, 17.3 Hz, 7.0 Hz, 7.0 Hz, 3.0  
                                                                          Hz, H-2'', 1H); 5.80 (ddd, 10.3 Hz, 2.7 Hz,
                                                                          1.9 Hz, H-5, 1H); 5.14-5.11 (m, H-3'', 2H),
                                                                          4.28- 4.20 (dddd, 7.8 Hz, 7.8 Hz, 4.1 Hz, 1.6 
                                                                          Hz, H-1', 2H); 4.15 (dd, 11.9 Hz, 3.5 Hz, 
                                                                          H-3, 1H); 3.96 (dd, 6.5 Hz, 5.0 Hz, H-6, 1H);
                                                                          3.47 (ddt, 14.6 Hz, 7.8 Hz, 6.8 Hz, H-2, 1H);
                                                                          2.32 (ddt, 14.3 Hz, 7.0 Hz, 5.9 Hz, 1.1 Hz, 
                                                                          H-1'', 2H), 2.09 (s, COCH3, 6H); 
13C NMR (100MHz, CDCl3, δ ppm)               δ = 170.82 (COCH3), 170.42 (COCH3),  
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                                                                          133.98 (C-2''), 132.82 (C-4), 123.71 (C-5), 
                                                                          117.59 (C-3''), 71.35 (C-3), 69.78 (C-2), 
                                                                           (C-6), 62.87 (C-1'), 37.87 (C-1''), 21.06 
                                                                           (COCH3), 20.08 (COCH3); 
MS (EI)                                                       253.1 (5%), 213.1 (68%), 153.0 (24%), 
                                                                           111.0 (100%), 94 (12%), 63 (20%); 
IR (Cap. film)                                                3460 (b), 2937 (s), 1732 (s), 1644 (s),
                                                                           1435 (s), 1231 (m), 1048 (m), 1031 (m), 
                                                                           915 (s);
HRMS                                               C13H18O5
                                                                           Calcld: 254.120
                                                                           Found: 254.116
(2S,3R,6S)-6-Allyl-2-hydroxymethyl-3,6-dihydro-2H-pyran-3-ol (100)
To a solution of the diacetate 154 (3.0 g, 11.8 mmol) in CH3OH (40 ml) was added K2CO3 
(6.9 g, 50 mmol) at room temperature. After stirring it for 1 h, the reaction mixture was 
quenched with saturated aqueous  NH4Cl and CH3OH was removed  in vacuo. The aqueous 
layer was extracted with EtOAc (7 x 25 ml). The combined organic layer was washed with  
brine, dried over MgSO4 and concentrated in vacuo to give the diol 100 (1.9 g, 11.1 mmol, 
95%). It was used for the next step directly. 
General Data:                                             C9H14O3, M = 170.21, yellowish oil; 
                                                                           Rf = 0.30 (Pe/EtOAc, 1:1); Vanillin: dark blue
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                                                                                                               [α]20 = +23.8° (c = 0.94 CHCl3); UV(-);
 1H NMR (400 MHz, CDCl3, δ ppm)              δ = 5.85-5.79 (m, H-2'', H-4, H-5, 3H); 5.14-
                                                                           5.10 (m, H-3'', 2H); 4.25-4.23 (m, H-3, 1H); 
                                                                           4.10 (d, 7.6 Hz, H-6, 1H); 3.83 (dd, 10.9 Hz,
                                                                           4.2 Hz, H-1', 1H); 3.78 (dd, 11.5 Hz, 4.2 Hz,
                                                                           H-1', 1H); 3.55 (ddt, 7.9 Hz, 5.9 Hz, 4.3 Hz,
                                                                           H-2, 1H); 2.50 (br, OH, 2H); 2.33 (ddt, 13.8
                                                                           Hz, 6.8 Hz, 6.0 Hz, H-1'', 1H); 2.30 (ddt, 13.8 
                                                                           Hz, 6.8 Hz, H-1'', 1H);
13C NMR (100MHz, CDCl3, δ ppm)              δ = 134.45 (C-2''), 130.58 (C-4), 128.61 (C-5) 
                                                                          117.60 (C-3''), 73.27 (C-2), 72.05 (C-6), 64.06
                                                                           (C-3), 62.91 (C-1'),  37.83 (C-1''); 
MS (EI)                                                            170.2 (15%), 169,2 (100%), 129.1 (100%), 
                                                                           111.1 (38%), 85.0 (64%), 55.0 (28%);
IR (Cap. Film)                                             3438 (b), 2930 (s), 1732(s), 1644 (s), 1384(s) 
                                                                           1257 (s), 918 (s), 729 (s), 578 (s);
HRMS                                                             C9H14O3
                                                                           Calcd: 170.090
                                                                           Found: 170.092
Experimental Part                                                                                                                  100
(2S,3R,6S)-6-Allyl-3-(tert-butyldimethylsilanyloxy)-2-(tert-butyldimethyl-
silanyloxymethyl)-3,6-dihydro-2H-pyran (76) 
The  diol  100 (800 mg,  4.7  mmol)  was  dissolved  in  pyridine  (10  ml,  12.6  mmol).  The 
reaction was cooled to 0 °C and TBSCl (1.74 g,  11.5 mmol)  was added to the reaction 
slowly[21]. The reaction was allowed to warm up to room temperature and stirred for another 
12 h. It was quenched with 5% aqueous NaHCO3 (11.2 ml) and was extracted with Et2O (3 x 
50 ml). The combined organic phase was dried over MgSO4 and volatiles were removed in 
vacuo.  The residue was purified by flash chromatography with Pentane:Ether  (100:1)  to 
afford TBS- protected alkene 76 (1.85 g, 4.64 mmol, 99%).   
General Data:                                          C21H42O3Si2, M = 398.73 g/mol, colorless oil; 
                                                                       Rf = 0.85 (100% EtOAc); Vanillin: dark blue; 
                                                                   [α]20  = - 28.9° (c = 0.98 CHCl3); UV(-); 
1H NMR (400 MHz, CDCl3, δ ppm)           δ = 5.81 (dd, 17.0 Hz, 7.1 Hz, H-2'', 1H); 5.64 
                                                                        (m, H-4, H-5, 2H) 5.05-4.98 (m, H-3'', 2H);
                                                                        4.12 (m, H-3, 1H); 4.00-3.99 (m, H-6, 1H); 
                                                                        1H); 3.79,3.63 (d, 11.0 Hz, H-1', 2H); 3.38 
                                                                        (ddt, 2.5 Hz, 6.0 Hz, 8.1 Hz, H-2, 1H); 2.47, 
                                                                        2.27 (m, H-1'', 2H); 0.84 (s, OTBS, 18H); 0.03 
                                                                        (s, OTBS, 6H); 0.02 (s, OTBS, 6H); 
13C NMR (100MHz, CDCl3, δ ppm)            δ = 134.01 (C-2''), 129.69 (C-4), 128.67 (C-5),
                                                                        115.90 (C-3''), 73.41 (C-2), 71.37 (C-6), 63.02 
                                                                        (C-3),  62.18 (C-1'), 37.78 (C-1''), 24.86 
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                                                                         (OSiC(CH3)3), 24.79 (OSiC(CH3)3), 17.31
                                                                        (OSiC(CH3)3), 17.08 (OSiC(CH3)3), -5.26
                                                                        (OSiCH3), -5.77 (OSiCH3), -6.12 (OSiCH3);
                                                                        -6.30 (OSiCH3); 
MS (EI)                                                      398.1 (15%), 383.2 (20%), 357.2 (9%), 341.1 
                                                                        (44%), 117.0 (100%), 73.1 (95%), 59 (20%); 
IR (Cap. Film)                                            3864 (s), 3468 (s),  2956 (s), 2930 (s), 2886
                                                                        (b), 2858 (s), 1473 (s), 1463 (s), 1255 (s), 
                                                                        1093 (s), 1020 (s), 878 (s), 837 (s), 777 (s); 
HRMS                                                       C21H42O3Si2, 
                                                                        Calcd: 398.270
                                                                        Found: 398.267
(2S,3R,6S)-5-(tert-Butyldimethylsilanyloxy)-6-(tert-butyldimethyl-
silanyloxymethyl)-5,6-dihydro-2H-pyran-2''-yl-acetaldehyde (156)
To a stirred solution of alkene 76 (220 mg, 0.58 mmol) in 50% THF/H2O (10 ml) solution 
was added NMO (81.6 mg, 0.70 mmol) and OsO4 (0.25 ml, 2.5% in t-BuOH) at 0 °C and the 
reaction was stirred vigorously at room temperature for 5 h. The reaction was quenched with 
1M Na2S2O3, extracted with EtOAc (3 x 50 ml) and dried over Na2SO4. The organic layer 
was concentrated in vacuo and purified by flash chromatography with Hexane:EtOAc (4:1 to 
1:2) to give the intermediate diol 155 (173 mg). To a solution of the intermediate diol 155 
(173 mg,  0.40 mmol)  in THF (10 ml)  was added a suspension of NaIO4 (288 mg,  1.62 
mmol) in H20 (2 ml) at 0 °C. The mixture was stirred for 3.5 h, extracted with EtOAc (4 x 25 
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ml) and dried over Na2SO4. The organic layer was concentrated in vacuo and purified by 
flash  chromatography  with  Pentane:EtOAc  (4:1)  to  afford  aldehyde  156 (140  mg,  0.35 
mmol, 61%).
General Data:                                            C20H40O4Si2, M = 400.70 g/mol, yellowish oil;
                                                                          Rf  = 0.63 (100% EtOAc); Vanillin:dark blue;
                                                                     [α]20 = -43.7° (c = 0.85 CHCl3); UV (-); 
1H NMR (400 MHz, CDCl3, δ ppm)             δ = 9.80 (dd, 2.3 Hz, 2.1 Hz, H-2'', 1H); 5.77
                                                                          (dd, 8.5 Hz, 1.8 Hz, H-4, 1H); 5.69 (dd, 8.5Hz
                                                                          1.6 Hz, H-5, 1H); 4.73 (m, H-6, 1H); 4.10 (m
                                                                          H-3, 1H); 3.81 (dd, 11.1 Hz, 2.7 Hz, H-1',1H);
                                                                          3.69 (ddt, 2.7 Hz, 5.6 Hz, 11.1 Hz, H-1', 1H); 
                                                                          3.41 (m, H-2, 1H); 2.56-2.52 (m, H-1'', 2H);
                                                                          0.89,0.88 (s, OSiC(CH3)3, 18H); 0.08,0.03 (s,
                                                                          OSi(CH3)2, 12H); 
13C NMR (100MHz, CDCl3, δ ppm)             δ = 200.75 (C-2''), 130.71 (C-5), 128.52 (C-4),
                                                                          74.64 (C-2), 68.01 (C-6), 63.43 (C -3), 62.71
                                                                          (C-1'), 46.75 (C-1''), 25.90 (OSiC(CH3)3),
                                                                          25.74 (OSiC(CH3)3), 18.37 (OSiC(CH3)3);
                                                                          18.00 (OSiC(CH3)3), -4.32 (OSiCH3), -4.82 
                                                                          (OSiCH3), -5.01 (OSiCH3), -5.34 (OSiCH3); 
MS (EI)                                                        401.2 (2%), 369.2 (26%), 355.2 (100%), 345.1
                                                                          (26%), 315.2 (31%), 272.1 (20%), 180.1
                                                                          (24%), 169.1 (11%), 75.0 (48%), 61 (100%);
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IR (Cap. Film)                                                    3432 (br), 3039 (s), 2930 (s), 2858 (m), 2179 
                                                                         (s), 1726 (s), 1544 (s), 1463 (s), 1375 (s), 1361
                                                                         (s), 1254 (s), 1087 (s), 939 (s), 881 (s), 838 (s),
                                                                         778 (s), 724 (s), 670 (s); 
HRMS                                                        C20H40O4Si2
                                                                         Calcd: 400.246
                                                                         Found: 400.247
(2S,3R,6S)-3-(tert-Butyldimethylsilanyloxy)-2-(tert-butyldimethyl-
silanyloxymethyl)-6-(2'',2''-dimethoxyethyl)-3,6-dihydro-2H-pyran (157)
To a solution of the aldehyde  156 (90 mg, 0.23 mmol) in abs. CH2Cl2  (2 ml) was added 
PPTS  (1.0  mg)  and  CH(OCH3)3 (167  mg).  The  reaction  was  stirred  for  2  h  at  room 
temperature  and  volatiles  were  removed  in  vacuo.  The  residue  was  purified  by  flash 
chromatography with Pentane:EtOAc (20:1) to afford 206 (67 mg, 0.15 mmol, 63%).
General Data:                                        C22H46O5Si2, M = 446.78 g/mol, yellowish oil; 
                                                                     Rf  = 0.69 (100% EtOAc); Vanillin: blue; UV (-);
                                                                 [α]20  = - 43.4 (c = 1.16 CHCl3);
1H NMR (400 MHz, CDCl3, δ ppm)        δ = 5.70-5.68 (m, H-4, H-5, 2H); 4.56 (m, H-2'', 
                                                                                                                      1H);  4.35 (d, 10.5 Hz, H-3, 1H); 4.12 (m, H-6,
                                                                    1H)); 3.81-3.65 (m, H-1', 2H); 3.36 (s, H-3'', 3H); 
                                                                    3.33 (s, H-4'', 3H); 2.04 (m, H-1'', 2H); 0.89 (s, 
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                                                                    OSiC(CH3)3, 18H); 0.10,0.09 (s, OSi(CH3)2,
                                                                     12H); 
13C NMR (100MHz, CDCl3, δ ppm)         δ = 130.15 (C-5), 129.45 (C-4), 102.52 (C-2''), 
                                                                     72.77 (C-2), 69.89 (C-3), 64.20 (C-1'), 62.56 
                                                                     (C-6), 53.53 (C-3''), 52.80 (C-4''), 35.58 (C-1''), 
                                                                     25.94 (OSiC(CH3)3), 25.74 (OSiC(CH3)3), 18.39
                                                                     (OSiC(CH3)3), 18.02 (OSiC(CH3)3), -4.82
                                                                     (OSiCH3), -4.90 (OSiCH3), -5.33 (OSi(CH3)2); 
MS (EI)                                                    446.3 (16%), 431.2 (28%), 389.2 (6%), 357.2
                                                                     (100%), 184.9 (17%), 88.9 (15%), 74.9 (100%); 
IR (Cap. Film)                                          2959 (s), 2937 (s), 2886 (s), 2852 (s), 1474 (s),
                                                                     1464 (s), 1119 (s), 1089 (s), 883 (m), 775 (s); 
HRMS                                                    C22H46O5Si2
                                                                     Calcd: 446.288
                                                                     Found: 446.290
(2S,3R,6S)-3-(tert-Butyldimethylsilanyloxy)-6-(2'',2''-dimethoxy-ethyl)-3,6-
dihydro-2H-pyranyl)-methanol (101)
To a solution of aldehyde  156 (200 mg, 0.5 mmol) in CH3OH (6.7 ml) was added I2 (0.2 
mmol, 15 mg) and was stirred for 5 h. The reaction was diluted with Et2O (10 ml) and 
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successively washed with 5% Na2S2O3 (5 ml), saturated aqueous NaHCO3  (5 ml) and dried 
over Na2SO4. The volatiles were evaporated in vacuo and purified by flash chromatography 
with Pentane:EtOAc (5:1) to afford the alcohol 101 (119 mg, 0.35 mmol, 70%).
General Data:                                         C16H32O5Si, M = 332.51 g/mol; yellowish oil;
                                                                        Rf  = 0.57 (100% EtOAc); Vanillin: dark blue;
                                                                        [α]20 = -57.7 (c = 1.05 CHCl3); UV(-); 
1H NMR (400 MHz, CDCl3, δ ppm)           δ = 5.72-5.67 (m, H-4, H-5, 2H); 4.56 (dd, 3.7 
                                                                        Hz, 7.1 Hz, H-2'', 1H); 4.35 (m, H-3, 1H); 4.12 
                                                                        (m, H-6, 1H); 3.80 (dd, 11.3 Hz, 2.7 Hz, H-1',
                                                                        1H); 3.63 (dd, 11.4 Hz, 5.7 Hz, H-1', 1H); 3.42
                                                                        (m, H-2, 1H); 3.35 (s, H-3'', 3H); 3.31 (s, H-4'',
                                                                        3H); 2.03-1.73 (m, H-1'', 2H); 0.88 (s,
                                                                        OSiC(CH3)3, 9H);  0.09,0.08 (s, OSi(CH3)2, 
                                                                        6H);                                                                     
13C NMR(100MHz, CDCl3, δ ppm)            δ = 130.14 (C-5), 129.44 (C-4), 102.50 (C-2''),
                                                                        72.77 (C-2), 69.86 (C-6), 64.18 ( C-3), 62.53
                                                                        (C-1'), 53.50 (C-3''), 52.78 (C-4''), 35.57 (C-1'')
                                                                        25.72 (OSiC(CH3)3), 17.96 (OSiC(CH3)3),
                                                                        -4.32 (OSiCH3), - 4.88 (OSiCH3);
MS (EI)                                                      332.2 (5%), 317.2 (25%), 315.2 (35%), 301.2 
                                                                        (15%), 281.1 (100%), 243.2 (15%), 117.1
                                                                        (12%),  89.1 (6%), 75.1 (100%);
IR (Cap. Film)                                             3470 (b), 2956 (s), 2930 (s), 2858 (s), 1739(s)
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                                                                        1472 (s), 1464 (s), 1388 (s), 1258 (s), 1086 (s), 
                                                                        1011 (s), 882 (s), 838 (s);
HRMS                                                       C16H32O5Si
                                                                        Calcd: 332.201
                                                                        Found: 332.202
(2S,3R,6S,1'S)-1'-[3-tert-Butyldimethylsilanyloxy-6-(2'',2''dimethoxy-
ethyl)-3,6-dihydro-2H-pyranyl]-ethanol (160)       
A solution of oxalyl chloride (60 mg, 0.47 mmol) in THF (0.15 ml) was cooled to -78 °C 
and DMSO (58.5 mg, 0.75 mmol) was added dropwise. After 1 h alcohol 101 (60 mg, 0.18 
mmol) was added to the mixture and the reaction was warmed to -30 °C and stirred for 2 h. 
The reaction was quenched with Et3N (90 mg, 0.92 mmol) warmed to 0 °C and CH3MgBr 
(0.1 ml, 3.0 M in THF) was added. After stirring for 24 h the reaction was quenched with 
freshly prepared saturated aqueous NH4Cl (1.25 ml) and stirred for 1 h. The mixture was 
extracted with Et2O (3 x 25 ml), the combined organic phase was dried over Na2SO4 and 
volatiles were concentrated in vacuo. The residue was purified by flash chromatography 
with Pentane:Ether (4:1) to afford 160 as yellowish oil (44.5 mg, 0.13 mmol, 73%).
General Data:                                         C17H34O5Si, M = 346.53 g/mol, yellowish oil;
                                                                        Rf  = 0.59 (100% EtOAc); Vanillin: dark blue;
                                                                    [α]20 = -63.4 (c = 1.60 CHCl3), UV(-); 
1H NMR (400 MHz, CDCl3, δ ppm)           δ = 5.74 (m, H-4, 1H); 5.66 (m, H-5, 1H); 4.57
                                                                        (dd, 8.1 Hz, 3.2 Hz, H-2'', 1H); 4.36 (m, H-3,
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                                                                        1H); 4.29 (dd, 3.9 Hz, 1.9 Hz, H-6, 1H); 3.99 
                                                                        (m, H-1', 1H); 3.38 (s, H-4'', 3H); 3.32 (s, H-3'', 
                                                                        3H); 3.13 (dd, 8.1 Hz,1.8 Hz, H-2, 1H);  2.04 (s
                                                                        OH, 1H); 1.93,1.75 (ddt, 14.3 Hz, 3.6 Hz, 8.1 
                                                                        Hz, H-1'', 2H); 1.29 (d, 6.7 Hz, H-2', 3H); 0.90
                                                                        (s, OSiC(CH3)3, 9H); 0.12 (s, OSi(CH3)2, 6H);
13C NMR (100MHz, CDCl3, δ ppm)            δ = 130.45 (C-5), 129.16 (C-4), 102.39 (C-2''), 
                                                                        75.06 (C-2), 69.89 (C-6), 65.24 (C-1'), 64.01
                                                                        (C-3), 53.87 (C-3''), 52.69 (C-4''), 35.83 (C-1''),
                                                                        25.79 (OSiC(CH3)3), 20.55 (C-2'), 18.01
                                                                        (OSiC(CH3)3); -4.26 (OSiCH3); - 4.78 
                                                                        (OSiCH3);
MS (EI)                                                      346.1 (5%), 257.2 (25%), 213.2 (35%), 199.2 
                                                                        (15%), 185.1 (65%), 159.9 (15%), 117.1 (12%)
                                                                        89.1 (6%), 75.1 (100%);
IR (Cap. Film)                                             3470 (b), 2956 (s), 2930 (s), 2896 (s), 2858(s)
                                                                        1388 (s), 1191 (s), 1087 (s), 882 (s), 777 (s);
HRMS                                                       C17H34O5Si,
                                                                        Calcd: 346.222
                                                                        Found: 346.228
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(2S,3S,6S)-1'-[3-tert-Butyldimethylsilanyloxy-6-(2'',2''-dimethoxyethyl)-
3,6-dihydro-2H-pyranyl]-ethanone (D)
To compound 102 (23 mg, 0.1 mmol) in THF (5 ml), was added 4-nitrobenzoic acid (36.4
mg, 0.2 mmol) and PPh
3 
(50.4 mg, 0.2 mmol). After 30 minutes DIAD (44 mg, 0.22 mmol) 
was  added  dropwise  at  a  rate  such  that  the  temperature  of  the  reaction  mixture  was 
maintained  below  10  °C.  The  solution  was  stirred  at  room  temperature  overnight  and 
subsequently at 40 °C for 3 h. The reaction mixture was cooled to room temperature, diluted 
with Et2O (15 ml), and washed with saturated aqueous NaHCO3 (10 ml). The aqueous layer 
was extracted with Et2O (100 ml) and combined organic layer was dried over Na2SO4   and 
volatiles were removed with vacuo. The residue was dissolved in CH3OH (3 ml) and K2CO3 
(30 mg, 0.22 mmol) was added at room temperature. After stirring it for 1 h, the reaction 
mixture was quenched with  saturated aqueous  NH4Cl and CH3OH was removed  in vacuo. 
The aqueous layer was extracted with EtOAc (7 x 25 ml) and the combined organic layer 
was washed with brine, dried over MgSO4 and concentrated in vacuo to give alcohol 162 (15 
mg, 0.065 mmol, 65%). Compound 162 was dissolved in pyridine (2.5 ml) and was treated 
with TBSCl (32.6 mg, 3 mmol) and stirred further for 12 h. The reaction was quenched with 
5% aqueous NaHCO3 (11.2 ml) and was extracted with Et2O (3 x 50 ml). The organic phase 
was dried over MgSO4 and volatiles were removed in vacuo. The residue was purified by 
flash chromatography with Pentane:Ether (10:1) to afford D (19 mg, 0.055 mmol, 85%).
General Data:                                           C17H32O5Si, M = 344.52 g/mol, yellowish oil; 
                                                                          Rf = 0.62 (100% EtOAc); Vanillin: blue;
1H NMR (400 MHz, CDCl3, δ ppm)             δ = 5.81-5.78 (m, H-4, H-5, 2H); 4.57 (dd, 7.8
                                                                          Hz, 3.6 Hz, H-2'', 1H); 4.37-4.33 (dd, 3.9 Hz, 
                                                                          1.8 Hz, H-2, H-6, 2H); 3.95 (m, H-3, 1H);
                                                                          3.36 (s, H-4'', 3H); 3.34 (s, H-3'', 3H); 2.27 (s,
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                                                                          H-2', 3H); 1.93,1.76 (ddt, 3.6 Hz, 8.2  Hz, 8.1
                                                                          Hz, H-1'', 2H); 0.86 (s, OSiC(CH3)3, 9H); 0.05
                                                                          0.03 (s, OSi(CH3)2, 6H);
13C NMR (100MHz, CDCl3, δ ppm)              δ = 206.50 (C-1'), 129.74 (C-5), 127.71 (C-4),
                                                                          102.10 (C-2''), 78.91 (C-2), 69.58 (C-6), 64.18
                                                                          (C-3), 53.78 (C-3''), 52.72 (C-4''), 36.56 (C-1'')
                                                                          27.72 (C-2'), 25.78 (OSiC(CH3)3), 18.03
                                                                          (OSiC(CH3)3), - 4.44 (OSiCH3), -4.78
                                                                          (OSiCH3); 
(2S,3R,6S)-1'-[3-tert-Butyldimethylsilanyloxy-6-(2'',2''-dimethoxyethyl)-
3,6-dihydro-2H-pyranyl]-ethanone (102)
To a solution of the alcohol 160 (102 mg, 0.3 mmol) in CH2Cl2 (2 ml), DMP (140 mg, 0.33 
mmol,  15% in CH2Cl2) was added and the reaction mixture was stirred for 4 h at room 
temperature. The volatiles were removed in vacuo and the crude product was purified by 
flash chromatography directly with Pentane:Et2O (1:1) to afford the Ketone 102 (96.2 mg, 
0.28 mmol, 94%).
General Data:                                           C17H32O5Si, M = 344.52 g/mol, yellowish oil;
                                                                          Rf = 0.63 (100% EtOAc); Vanillin: dark blue;
                                                                          [α]20 = -51.4 (c = 1.60 CHCl3); UV(-); 
1H NMR (400 MHz, CDCl3, δ ppm)             δ = 5.76-5.68 (m, H-4, H-5, 2H); 4.59 (dd, 7.8
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                                                                          Hz, 3.7 Hz, H-2'', 1H); 4.36-4.34 (dd, 4.1 Hz,
                                                                          2.0 Hz, H-2, H-6, 2H); 3.95 (m, H-3, 1H); 
                                                                          3.37 (s, H-4'', 3H); 3.32 (s,  H-3'', 3H); 2.26 (s,
                                                                          H-2', 3H); 1.95,1.78 (ddt, 3.6 Hz, 8.1 Hz, 8.1 
                                                                          Hz, H-1'', 2H); 0.89 (s, OSiC(CH3)3, 9H); 0.08
                                                                          0.05 (s, OSi(CH3)2, 6H);
13C NMR (100MHz, CDCl3, δ ppm)              δ = 206.49 (C-1'), 129.73 (C-5), 128.72 (C-4) 
                                                                          102.09 (C-2''), 78.90 (C-3), 69.57 (C-6), 64.16
                                                                          (C-2), 53.77 (C-4''), 52.71 (C-3''), 36.54 (C-1'')
                                                                          27.71 (C-2'), 25.77 (OSiC(CH3)3), 18.02
                                                                          (OSiC(CH3)3), - 4.45 (OSiCH3), -4.80 
                                                                          (OSiCH3);
MS (EI)                                                        343.9 (2%), 288.3 (5%), 257.1 (25%), 255.2
                                                                          (34%), 230.9 (5%), 197.1 (80%), 155.2 (40%) 
                                                                          89.1 (20%), 75 (100%);
IR (Cap. Film)                                              2957 (s), 2930 (s), 2858 (s), 1739 (s),1472 (s), 
                                                                          1464 (s), 1362 (s), 1258 (s), 1191 (s), 778 (s);
HRMS                                                                 C17H32O5Si
                                                                             Calcld: 344.200
                                                                          Found: 344.202
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3-(tert-Butyl-dimethyl-silanyloxy)-2-(tert-butyl-dimethylsilanyloxy-
methyl)-6-(6-triisopropylsilanyloxy-hex-2''-enyl)-3,6-dihydro-2H-pyran 
(190)
To a stirred solution of fragment F (21 mg, 0.05 mmol, 1.17equiv.) in THF (5 ml), cooled to 
-78 °C was added LDA (0.02 ml, 2M in THF) dropwise. The reaction was stirred at the same 
temperature for 10 minutes, the bright yellow mixture was treated with aldehyde  156 (20 
mg, 0.12 mmol) dissolved in THF (1.0 ml) and stirred for 3 h during this time the reaction is  
slowly warmed to room temperature.  The reaction was quenched with saturated aqueous 
NH4Cl and the aqueous phase was extracted with Et2O (3 x 25 ml). The combined organic 
phase was dried over MgSO4 and volatiles were removed in vacuo. The residue was purified 
with  flash  chromatography by using  Pentane:Ether  (10:1)  to  afford  190 (16.8  mg,  0.03 
mmol, 57%).
General Data:                                         C31H64O4Si3, M = 585.09 g/mol, white solid; 
                                                                      Rf = 0.91 (100% EtOAc); Vanillin: brown;
                                                                       [α]20 = +81.7 (c = 1.0 CHCl3); UV(-); 
1H NMR (400 MHz, CDCl3, δ ppm)          δ = 5.74-5.71 (m, H-4, H-5, 2H), 5.52-5.51 
                                                                       (m, H-2'', H-3'', 2H); 4.08 (m, H-3, 1H); 3.83-.   
                                                                       3.73 (m, H-4'', H-1', 4H); 3.66 (m, H-6, 1H);
                                                                       3.49 (ddt, 2.5 Hz, 6.0 Hz, 8.1 Hz, 1H, H-2);
                                                                       2.17-1.96 (m, H-1'', H-5'', 4H); 1.59 (m, H-1'',
                                                                       H-4'', 2H); 1.39,1.16 (m, OTIPS, 21H); 0.89 (s, 
                                                                      OTBS, 18H), 0.09,0.06 (s, OTBS, 12H); 
O
OTBS
OTBS
OTIPS
1'
2
3
4
5
6
2''
1''
3''
4''
5''
6''
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13C NMR (100MHz, CDCl3, δ ppm)           δ = 132.58 (C-3''), 129.94 (C-5), 129.46 (C-4),
                                                                       126.36 (C-2''), 74.42 (C-2), 72.88 (C-6), 64.11 
                                                                       63.23 (C-6''), 62.89 (C-1'), 36.64 (C-4''), 29.70
                                                                       29.70 (C-1''), 25.97 (OSiC(CH3)3), 25.75 
                                                                       (OSiC(CH3)3), 18.44 (OSiC(CH3)3), 18.02 
                                                                       (OTIPS), 11.98 (OTIPS), -4.25 (OSi(CH3)2),
                                                                       -4.75 (OSi(CH3)2);
MS (EI)                                                     555.8 (12%), 554.8 (25%), 436.8 (8%), 356.9
                                                                      (100%), 224.9 (15%), 157.0 (32%), 116.2 (98%) 
                                                                      81.0 (52%), 73.0 (100%); 
IR (Cap. Film)                                            3434 (b), 3036 (s),  2929 (s), 2859 (s), 2738
                                                                       (s), 2032 (s), 1734 (s), 1689 (s), 1626 (s), 
                                                                       1530 (s), 1463 (s), 1361 (s), 1254 (s), 1095 (s), 
                                                                       882 (s), 837 (s), 777 (s), 680 (s);
HRMS                                                              C30H61O4Si3
                                                                          Calcld (M+ -CH(CH3)2): 569.390
                                                                       Found: 569.388 
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9 Spectral Data    
D-Valine-hydrochloride-methylester
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(R)-2-Amino-3-methyl-1, 1-diphenylbutane-1-ol 
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HO H NH2
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4(R) –Isopropyl-5, 5-diphenyl-oxazolidin-2-on 
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3-Hept-6-enoyl-4(R)-Isopropyl-5,5-diphenyl-oxazolidin-2-on
   
O N
O
Ph
Ph
O
1 2 3 4
5
6
7
2'
4'5'
6'
Spectral Data                                                                                                                        121
(2R, 4’R)-Isopropyl-3-(2-methyl-hept-6-enoyl)-5,5-diphenyl-oxazolidin-2-on  
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(2R)-5-(2-Methyl-hept-6-enylsulfanyl)-1-phenyl
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5-Hept-6-enylsulfanyl-1-phenyl-1H-tetrazole
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5-(Hept-6-ene-1-sulfonyl)-1-phenyl-1H-tetrazole
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5-(1-Methyl-hept-6-enylsulfanyl)-1-phenyl-1H-tetrazole
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5-(Oct-7-ene-2-sulfonyl)-1-phenyl-1H-tetrazole
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(2R)-2-(2-Methylhept-6-enylsulfanyl)-Benzothiazol
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(2R)-2-(2-Methylhept-6-en-1-sulfonyl)-Benzothiazol
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2-Triisopropylsilanyloxy Ethanol
   
HO
OTIPS
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2-(tert-Butyldimethylsilyloxy) Ethanol
OTBS
HO
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2-(Triisopropylsilyloxy) acetaldehyde
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2-(tert-Butyldimethylsilyloxy) Acetaldehyde
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Acetic acid 2-hydroxy-ethyl ester 
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OAc
Spectral Data                                                                                                                        134
Acetic acid 4-acetoxy-but-2-enyl ester
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(2S,3S)-2,4-bis(tert-Butyldimethylsilyloxy)-3-hydroxybutanal
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3-(tert-Butyl-dimethyl-silanyloxy)-2-(tert-butyl-dimethyl-silanyloxymethyl)-3,4-dihydro-2H-pyran-4-ol 
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Acetic acid 3-acetoxy-2-acetoxymethyl-3,4-dihydro-2H-pyran-4-yl ester
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(2S,3R,6S)-3-Acethoxy-2-acethoxymethyl-6-allyl-3,6-dihydro-2H-pyran 
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(2S,3R, 6S)-6-Allyl-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-ol 
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(2S,3R,6S)–6-Allyl-3-tert-butyldimethylsilanyloxy-2-tert-butyldimethyl-silanyloxymethyl-3,6-dihydro-
2H-pyran                                                            
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(2S,3R,6S)-5-ter-Butyldimethylsilanyloxy-6-tert-butyldimethyl-silanyloxymethyl-5,6-dihydro-2H-
pyran-2-yl-acetaldehyde
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(2S,3R,6S)-tert-Butyldimethylsilanyloxy-6-(2,2-dimethoxy-ethyl)-3,6-dihydro-2H-pyranyl)-methanol 
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(2S,3R,6S)-1-3-tert-Butyldimethylsilanyloxy-6-(2,2-dimethoxyethyl)-3,6-dihydro-2H-pyranyl)-ethanol    
2''
1'' O
OTBS
6 2
3
4
5
1'
O O
3''4''
OH
1'''
Spectral Data                                                                                                                        144
(2S,3R,6S)-1-3-tert-Butyldimethylsilanyloxy-6-(2,2-dimethoxyethyl)-3,6-dihydro-2H-pyranyl-ethanon 
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